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DEVELOPMENT OF A PEDIATRIC CARDIAC ASSIST MAGLEV PUMP FOR 
USE WITH A UNIVERSAL DRIVER SYSTEM 
 
Landon H. Tompkins 
November 24, 2020 
 
Heart failure (HF) remains the leading cause of death, affecting 26 million 
adults worldwide and 6.5 million adults in the United States. Pediatric HF patients 
have been a historically underserved population with few options for mechanical 
circulatory support (MCS) therapy, a leading treatment as an alternative to heart 
transplantation. To address this clinical need, the Inspired Universal MagLev 
System is being developed; a low cost, universal magnetically levitated 
extracorporeal MCS system with interchangeable single-use pumps that will 
ultimately provide adult and pediatric patients ventricular and respiratory assist 
therapies. The Inspired Pediatric VAD is the first single-use pump application for 
this MCS system and is specifically designed for pediatric circulatory support. 
This dissertation describes the development efforts to design and evaluate 
iterative impeller and pump housings for the Inspired Pediatric VAD.  
Requirements for the Inspired Pediatric VAD design include the need to 
generate the appropriate hemodynamic parameters (pressures and flows) for 
pediatric patients, and miniaturization of the pump and impeller to accommodate 
the pediatric population. Traditional pump theory and design methods were 
 
 vi 
applied to aid in the unique design of the VAD impeller and pump housing, 
resulting in multiple design iterations. Two impeller and pump designs (V1, V2) 
were virtually constructed using computer-aided design (CAD) software. Three-
dimensional flow and pressure features were analyzed using computational fluid 
dynamics (CFD) analysis. Simulated pump designs (V1, V2) were operated at 
15% higher rotational speeds (~5000 rpm) than initially estimated (4255 rpm) to 
achieve the desired operational point (3.5 L/min flow at 150 mmHg). V2 design 
outperformed V1 by generating up to 30% higher pressures at all simulated 
rotational speeds and with 5% lower priming volume. Simulated hydrodynamic 
performance (flow, pressure and hydraulic efficiency) of VAD V2 compared 
favorably to current commercially available MCS devices. 
A prototype of the Inspired Pediatric VAD V2 was fabricated, the 
magnitude and range of hydraulic torque and forces of the impeller were 
quantified, and the hydrodynamic performance benchmarked. A static mock flow 
loop model containing a heated blood analogue solution was created to test the 
pump over a range of rotational speeds (500 - 6000 RPM), flow rates (0 - 3.5 
L/min), and pressures (0 to ~420 mmHg). The device was initially powered by a 
shaft driven DC motor, which was used to calculate the fluid torque acting on the 
impeller. Additional CFD simulations of VAD V2 were compared against the 
empirical bench-top data at select rotational speed and flow rate conditions. 
Empirically, the pediatric VAD produced flows as high as 4.3 L/min against a 
pressure of 127 mmHg at 6000 RPM.  
 
 vii 
Based on the performance of the first two VAD design iterations, a final 
design iteration, VAD V3, was achieved. Hydrodynamic performance of VAD V3 
was numerically assessed using CFD simulations. The results indicated no 
change in flow and pressure head performance compared to the previous device 
design (V2). Shear stress and flow residence time volumetric distributions were 
generated over a range of pump rotational speeds and flow rates. At the lowest 
pump operating point (3000 RPM, 0.50 L/min, 75 mmHg), 79% of the pump 
volume was in the shear stress range of 0 – 10 Pa with < 1% of the volume in the 
critical range of 150 – 1000 Pa associated with potential for increased risk of 
clinically-significant blood damage. At higher speed and flow (5000 RPM, 3.50 
L/min, 176 mmHg), 65% of the volume resided in the 0 – 10 Pa range compared 
to 2.3% at 150 – 1000 Pa. The initial results from the computational 
characterization of the Inspired Pediatric VAD V3 were encouraging, and based 
on the overall research performed to date, future work will include pre-clinical 
testing of VAD V3 in static and dynamic mock flow loop and acute large animal 
model studies to further assess device function, hydrodynamic performance, 
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CHAPTER 1 : INTRODUCTION 
 
1.1 Significance 
1.1.1 Adult Heart Failure 
Heart failure (HF) remains the leading cause of death, affecting an 
estimated 26 million people worldwide [1], [2]. HF affects approximately 6.5 
million adults in the United States with a projected increase in prevalence of 46% 
by 2030 [3]. In 2012, the direct and indirect costs of HF treatment in the United 
States was $31 billion and is projected to increase to $70 billion by 2030 [4]. 
Globally, the economic burden of HF is estimated at $108 billion annually [5]. 
Heart transplantation continues to be the preferred option for long-term 
survival with end stage HF patients, but the number of transplant candidates 
continues to outpace the donor pool each year. In 2018, 2,967 adult heart 
transplantations were performed in the US, while 3,883 new transplant 
candidates were added [6]. Currently in 2020, there are 3,487 patients awaiting a 
heart transplantation in the U.S. [7]. Mechanical circulatory support (MCS) has 
emerged as a promising alternative therapy for advanced HF patients over the 
last few decades. MCS devices have been used successfully for treating multiple 
modalities, including left, right, or bi-ventricular support (LVAD, RVAD, BiVAD), 
cardiopulmonary support (ECMO), and cardiopulmonary bypass (CPB). 
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Extracorporeal MCS systems, such as the Inspired MCS system under 
development, can be used as a bridge-to-decision (BTD) to stabilize the patient 
until they either recover, undergo heart transplantation (BTT) or to a longer-term 
intracorporeal ventricular assist system. Implantable ventricular assist systems 
may also be used for destination therapy (DT).  
 
1.1.2 Pediatric Heart Failure 
MCS is perceived as the best option for maintaining growth and 
development in pediatric HF patients as an alternative to transplantation, but the 
development of MCS devices specifically for the pediatric population has been 
greatly outpaced compared to those for adults [8], [9]. Up to 14,000 children are 
hospitalized with HF-related conditions each year in the U.S., with an overall 
mortality of 7% [10]. In 2018, 685 new pediatric transplantation candidates were 
added to the waiting list with only 473 transplants performed [6]. Currently, 17% 
of pediatric patients listed for HT die each year while waiting for a donor organ, 
which is the highest wait-list mortality rate of any organ in the U.S. [11].  
 
1.1.3 Pediatric Ventricular Support  
Several attempts have been made to develop MCS devices for pediatric 
HF patients since the National Heart, Lung, and Blood Institute (NHLBI) initiated 
the Pediatric Circulatory Support Program and Pumps for Kids, Infants, and 
Neonates (PumpKIN) trial in 2004. NHLBI provided over $23 million in 
development funding to support the PumpKIN program [12]. Of the many devices 
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funded in this effort, the Jarvik 2015 VAD is the only one still actively being 
developed [13]. Fully implantable devices such as the Jarvik 2015 have raised 
concern among the pediatric clinical community due to invasiveness of surgical 
procedure, post-op recovery, wide range of patient size, and patient growth 
during treatment [14]. Alternatively, extracorporeal devices present an excellent 
option for continued pediatric patient support through growth and development. 
Unfortunately, the majority of extracorporeal devices available to pediatric 
patients are intended for adult use [15]. 
 
1.1.4 Limitations of Current Technology 
There are many MCS devices available for the adult HF population for a 
variety of different indications for use, each with their own unique technology, 
modes of operation, and user interfaces. Keeping up with training and knowledge 
of the varying devices can be daunting for patients, caregivers, and clinicians, 
which may contribute to the risk of human errors with post-op management and 
long-term support. At present, there are limited MCS options specific to the 
pediatric HF population. Adding to the complexity of currently available adult 
MCS systems is the economic burden with mean costs of $175,420 for LVAD 
implantation and $90,147 for pump replacement [16]. Additionally, the majority of 
clinically available extracorporeal systems are large, bulky, bedside units and 
many use permanent bearings for pump impeller rotation, which can lead to 




1.1.5 Inspired Pediatric VAD and Universal MagLev System 
The Inspired Universal MagLev system is a new extracorporeal MCS 
therapeutic option aimed at addressing each of the limitations associated with 
current devices. The Inspired system features a single motor/controller unit that 
will utilize interchangeable magnetically levitated (MagLev) single-use pumps for 
treatment of multiple pediatric and adult cardiopulmonary indications. The first 
single-use pump developed for the system is intended for pediatric left, right, and 
biventricular support (Inspired Pediatric VAD), which is the focus of this 
dissertation. This new system intends to improve upon current MCS offerings by: 
 
1. Creating a Universal System 
Developing a single integrated pump/motor/controller system with a 
simple user interface and control scheme that can be used for multiple 
patient populations (neonate, pediatric, adult) and indications (circulatory 
support, ECMO, CPB) that will streamline device training and ideally 
mitigate clinician and caretaker errors. 
 
2. Creating Modular Pumps for Multiple Indications 
A universal integrated motor/controller designed to drive single-use 
adult and pediatric ventricular and respiratory assist pumps for up to 30 
days of support, and thereby potentially reducing development times and 








Miniaturization of electronic and magnetic motor components and 
integration of multiple peripherals into a single functional unit allows for 
the creation of a universal system with less complexity, lower cost, and 
may allow for patient ambulation during treatment. 
 
4. Improving Durability 
Utilization of MagLev technology to levitate and rotate the 
impeller/rotor within the pump housing eliminates pump parts from coming 
in contact with the blood stream, which may lead to improved device 
hemocompatibility, durability, and longevity. 
 
5. Reduced Cost 
Combining individual components into a single universal system and 
utilizing lower cost materials (polycarbonate) to manufacture single-use 
pump components reduces the cost of the device. Additionally, hospitals 
will be able to purchase and train clinical caretakers on a single system that 
supports multiple clinical applications rather than needing to purchase and 
train staff on multiple more expensive devices, which may lead to 
significant cost savings with the use of the Inspired System. Additional 








Table 1-1.  Summary of feature goals for the Inspired Pediatric VAD and 
Universal MagLev System. 
 
1.2 Aims and Objectives 
1.2.1 Aim 
The overall aim for this project was to design, develop, and evaluate the 




This aim was achieved through the completion of the following project 
objectives: 
Goals of the Inspired Pediatric VAD and Universal MagLev System 
Size 
System (pump, motor, controller) fits into a single enclosure 
approximately 5 inches tall and 2.6 inches in diameter (equivalent to a 
7.5 oz. container). 
Weight Less than 2 lbs. 




¼ inch connectors 
Single Controller for Multiple 
Indications 
• Pediatric VAD 
• Adult VAD 
• Respiratory Assist Device 
• ECMO 
• CPB 
Wearable • Patients able to ambulate to accelerate recovery 
Improved Quality of Life • Not bedridden and tethered to a stationary console 
Reduces Risk of Human 
Errors 
• Caretakers trained on one system that can be used in any 
hospital setting (OR, ICU, Stepdown Units) 
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- Define required operational and physiological parameters of the 
Inspired Pediatric VAD (Chapter 3) 
- Design the Inspired Pediatric VAD impeller geometry through 
calculation and dimensional analysis (Chapter 2) 
- Develop a computational fluid dynamics (CFD) model to evaluate the 
Inspired Pediatric VAD impeller and pump design (Chapter 3) 
- Characterize the Inspired Pediatric VAD hydrodynamic performance 
and impeller torques and forces through CFD prediction (Chapter 3 & 
Chapter 4) 
- Construct a prototype of the Inspired Pediatric VAD and characterize 
the hydrodynamic performance and impeller torque in vitro using a 
static flow loop model (Chapter 4) 
- Characterize and evaluate the hydro- and hemodynamics of the final 
Inspired Pediatric VAD design through CFD prediction (Chapter 5) 
 
1.3 Overview 
This dissertation is comprised of four core research manuscripts, each 
presented as individual chapters (Chapters 2 – 5) that describe the different 
phases of the Inspired Pediatric VAD development. The four manuscripts have 
been submitted to scientific journals for peer-review. Figure 1-1 illustrates the 
flow of the VAD project. The different phases of the project are highlighted to 





Chapter 2 provides the calculations and dimensional analysis techniques 
used to design the first iteration of the VAD impeller (VAD V1) to meet the 
circulatory requirements of the pediatric population. Chapter 3 describes the 
construction of a computational fluid dynamics (CFD) model to simulate and 
evaluate the initial VAD V1 design as well as improved 2nd generation iterative 
Figure 1-1.  Flow of the Inspired Pediatric VAD development project with 
dissertation chapter areas highlighted. 
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design, VAD V2. Chapter 4 presents CFD simulation studies for the shaft-driven 
VAD V2 design and mock loop test results, which aided in the design of the novel 
MagLev motor system. Chapter 5 describes the final iteration of the 
impeller/pump design (VAD V3) along with the hydrodynamic and hemodynamic 











CHAPTER 2 : IMPELLER DESIGN OF AN 
EXTRACORPOREAL 
PEDIATRIC LVAD FOR 




1 1 21,31,2 
2.1 Preface 
Inspired Therapeutics (Merritt Island, FL), in collaboration with the 
University of Louisville (Louisville, KY), is developing a miniature universal 
motor/controller to drive single-use extracorporeal pumps and integrated 
pump/oxygenators in multiple settings (OR, ICU, step-down units) with the 
objective of minimizing the risk of human errors. Training on a single universal 
controller for multiple indications for use throughout hospital settings, rather than 
on a number of different types of controllers, promises to reduce the risk of 
human errors. Moreover, the controller is miniaturized for use either in a bench 
top configuration or as a wearable device to allow patients to ambulate earlier in 
their postoperative recovery period. This article focuses on the first of a series of 
 
Authors:  1Landon H. Tompkins, MEng., 2Barry N. Gellman M.S., 1,3Steven C. Koenig Ph.D., 
1,2,3Kurt A. Dasse Ph.D. 
1   Department of Bioengineering, University of Louisville, Louisville, KY 
2   Inspired Therapeutics LLC, Merritt Island, FL  




pumps and pump/oxygenators to be developed, the Inspired Pediatric VAD, to be 
used with the Inspired Universal MagLev System (Figure 2-1). The Inspired 
Pediatric VAD is intended to provide circulatory support for up to 30-days for 
neonates and pediatric patients. 
Figure 2-1. Rendering of the Inspired Universal MagLev System and Pediatric 
VAD single-use pump concepts. The dimensions for the system are 
5 in. by 2.6 in. (the size of a 7.5 oz container) making it a small and 
compact device to allow for potential patient ambulation during 
treatment. 
 
In this article, we detail the initial concept formation and preliminary 
calculations to design the impeller for the first single-use pump head for use with 
the Inspired Universal MagLev System, the Inspired Pediatric VAD, intended to 
provide systemic circulatory support for pediatric patients (<40 kg weight) with 
diseases such as cardiomyopathy, myocarditis, and congenital malformations. 
 
 12 
There are many well established theoretical and experimental approaches and 
methodologies for the development of traditional turbomachinery that have also 
been applied to the design of ventricular assist devices (VADs), including 
centrifugal and axial rotary pumps. Designing an impeller for a rotary blood pump 
requires balancing the hydrodynamic demands of the pump with its 
hemocompatibility (hemolysis rate), which is key to clinical success [19]–[21]. 
Typically, impeller development requires a combination of traditional pump theory 
calculations, computational fluid dynamics (CFD) simulations, and empirical 
prototype evaluation, which are used to design and develop a clinically relevant 
impeller [20]. A first step in this process is to establish operational parameters for 
the device (pressures, flows) and then apply pump theory to determine the 
geometries of the impeller body and blades. In this article, traditional pump 
theory methodologies used to calculate the initial design of the Inspired Pediatric 
VAD centrifugal pump miniaturized impeller is presented. 
 
2.2 Impeller Rotational Speed Estimation  
First, the design point, including desired flow rate (Q) and head pressure 
(ΔP) at a corresponding rotational speed (n) as well as the diameter (outer) of the 
impeller (D2), was defined (Table 2-1) as previously reported [22]. Next, the 
empirical work of Cordier [23], Stepanoff [24], and Pfleiderer [25] was applied to 
calculate non-dimensional values and estimate the rotational speed of the 
impeller at the desired design point as follows:  
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Specific work of the pump (Y, Equation 2.1) was calculated to determine 
the diameter (𝛿, Equation 2.2). Using these values, a corresponding speed 
number of 𝜎 = 0.125 was found using a modified Cordier Diagram (Figure 2-2). 
The estimated rotational speed (n) was then calculated through modification of 


























































Table 2-1.  Example of design parameters required for the development of the 
Inspired Pediatric VAD, including maximum head and flow rate and 
impeller outer diameter as well as fluid parameters for whole blood. 
 
2.3 Determination of Pump Specific Speed 
The concept of dimensional analysis was applied to aid in developing a 
pump design based on maximum efficiency for the required design point [26]. In 
opposition to the design of industrial pumps, in the design of blood pumps, pump 
efficiency is typically secondary to the hemocompatibility of the design; however, 
the Inspired Pediatric VAD was designed for maximum efficiency, but will likely 
be modified later in the development process to improve hemocompatibility, if 
needed, at the expense of hydraulic efficiency.  
To implement dimensional analysis, the variables describing the pump (Q, 
ΔP, n, D) were reduced to a smaller group of dimensionless numbers to 
Design Parameters 
Parameter Symbol Value 
Maximum Pressure Head ΔP 150 mmHg 0.199x105 N/m2 2.90 psi 
Maximum Flow Rate Q 3.5 L/min 5.833x10-5 m3/sec 0.925 Gallon/min 
Impeller Outer Diameter D2 27.4 mm 0.0274 m - 
 
Natural Parameters 
Parameter Symbol Value 
Blood Density  ρ 1060 kg/m3 
Blood Viscosity   μ 0.003 N*sec/m2 
Gravitational acceleration   g 9.81 m/sec2 
Specific Gravity of Blood SG 1.0506 @ 37°C 
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characterize the resulting pump design. In this manner, a complete equation 
involving all dimensionless numbers was created, providing a relationship 
between all dimensioned variables (known or unknown) defining the pump. 
Dimensionless variables for pump design include specific speed, hs, speed 
constants, Km1 and Km2, head coefficient, Ψ, and flow coefficient, ɸ. Per 
Stepanoff’s [24] method for the dimensionless specific-speed calculation, ΔP was 
converted to feet head (H) to satisfy the units. Pump specific speed (hs) was 






1.0506 					= 					6.38	𝑓𝑒𝑒𝑡	ℎ𝑒𝑎𝑑	𝑜𝑓	𝑏𝑙𝑜𝑜𝑑 












					= 					𝟏𝟎𝟏𝟗. 𝟓 




Figure 2-2. Modified Cordier diagram detailing relationships between diameter 
number, 𝛿, speed number, 𝜎, and pump types radial, diagonal, and 
axial. Reproduced from [27] with permission. 
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2.4 Solve Euler Velocity Triangles 
Velocity vectors in one-dimension were estimated for any point along the 
fluid flow path through a pump impeller (Figure 2-3A). Graphically, the shape of 
these vectors forms a triangle for each point that is explored. The two most 
critical points are the entrance and discharge regions of the impeller blades. At 
these points, the fluid flow can be described by three velocity vectors: (1) relative 
velocity of the fluid, 𝜔, which is relative to the rotation of the impeller; (2) absolute 
velocity of the fluid, c, which is relative to the pump housing; and (3) peripheral 
velocity of the impeller, u, relative to the center axis. Two velocity triangles were 
used to characterize the impeller blade: (1) entrance or inlet triangle with 
subscript 1, and (2) discharge or exit triangle with subscript 2 (Figure 2-3B and 
C). These velocity vectors are governed by Euler’s pump equations and 
represent one-dimensional flows under ideal conditions (frictionless) [28]. The 
vectors are further be related by two angles: (1) absolute flow angle, 𝛼, in relation 
to the absolute flow velocities; and (2) relative flow angle, β, in relation to the 
relative flow velocities, which also corresponds to the angle of the impeller blade 
at that point. 
Following the methods of Stepanoff [24], the Euler velocity triangles were 
solved. The blade discharge or exit angle, β2, is critical in determining the 
impeller design constants (dimensionless numbers). β2 also directly impacts the 
shape (steepness) of the pump pressure head and flow relation (HQ curves). 
Backward swept blades (β2 < 90°) have been shown to induce less blood 


























































































































































































































According to Stepanoff [24], for a single-stage centrifugal pump at 
optimum efficiency, β2 is between 17.5° and 27.5°. Additionally, β2 in the range of 
15° and 30° has been shown to provide a good balance between impeller 
efficiency and induced hemolysis [30]. For the Inspired Pediatric VAD, β2 = 22.5° 
was selected for preliminary design as a tradeoff between optimal efficiency and 
hemocompatibility.   
Speed constants are design constants used by Stepanoff [24] and others 
to relate the pump total head to the impeller peripheral velocity, U. Entrance and 
discharge speed constants, Km1 and Km2, were used to help determine the 
absolute meridional velocity of the fluid, Cm. Figure 2-4 illustrates the values 
used to determine speed constants based on the pump’s specific speed, which 
for our Pediatric VAD resulted in Km1 = 0.195 and Km2  = 0.138. Head and flow 
coefficients serve as design constants representing the head potential (pressure) 
and capacity potential (flow) of the pump. Figure 2-5 illustrates the values used 
to determine head and flow constants based on the pump’s specific speed, which 
for our Pediatric VAD resulted in coefficients of Ψ = 0.515 and ɸ = 0.115. 
With all design constants determined, the Euler velocity discharge and 
entrance triangles were solved for ideal flow conditions. Solving the discharge 
triangle, the discharge blade tip speed, u2, as well as the meridional, Cm2, 
tangential, Cu2, and total absolute, C2, velocities of the fluid were calculated. 
From these, the absolute fluid discharge angle, 𝛼2, and the height of the impeller 
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blade at discharge, b2, can be determined (Appendix A, Equations A.1 – A.6). 
The entrance blade tip speed, u1, as well as the meridional, Cm1, tangential, Cu1, 
and total absolute, C1, velocities of the fluid can be calculated by solving the 
entrance triangle, the absolute fluid entrance angle, 𝛼1, so the entrance blade 
angle, β1, can be determined (Appendix A, Equations A.7 – A.12). To complete 
the solution of the entrance side of the impeller, the eye diameter D1, and 
Figure 2-4.  Impeller design constants Km1 and Km2 versus pump specific speed 




entrance blade height, b1, were determined (Equations 2.6, 2.7). Tuzson [28] 
provides an equation to calculate the eye diameter for single-stage pumps with 
low specific speed (<5000). All calculated entrance and discharge triangle 
parameter values for the Inspired Pediatric VAD impeller are shown in Table 2-2.  
 























					= 				1.93	𝑚𝑚	 → 2.00	𝑚𝑚  (2.7) 
 
 
Figure 2-5. Head coefficient Ψ and flow coefficient ɸ versus pump specific 




Table 2-2. All calculated parameter values for the entrance and discharge Euler 
velocity triangles under ideal flow conditions for the Inspired Pediatric 
VAD impeller. 
Blade Entrance Triangle Blade Discharge Triangle 
Blade Tip Speed u1 (m/sec) 1.78 Blade Tip Speed 
u2 
(m/sec) 6.10 
Meridional Velocity Cm1 (m/sec) 1.20 Meridional Velocity 
Cm2 
(m/sec) 0.85 
Tangential Velocity Cu1 (m/sec) 0.002 Tangential Velocity 
Cu2 
(m/sec) 4.05 
Total Absolute Velocity C1 (m/sec) 1.20 Total Absolute Velocity 
C2 
(m/sec) 4.14 
Fluid Entrance Angle 𝛼1 (°) 89.90 Fluid Discharge Angle 
𝛼2 
(°) 11.88 
Blade Entrance Height b1 (mm) 2.00 Blade Discharge Height 
b2 
(mm) 1.00 




2.5 Account for Flow Slip, Recirculation, and Pre-Rotation 
Under ideal conditions, flow passing through the impeller blade and exiting 
the blade tip will follow the flow path directed by the blade exit angle, β2. In 
practice, with the addition of friction forces and other flow variances and losses, 
the exiting flow will follow a path that is less than ideal and “slip” (𝛼2′ and β2′) [28]. 
This is due, in part, to the relative circulation of flow particles between impeller 
blades, which reduces the tangential velocity, Cu, at the blade exit but increases 
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at the blade entrance. To account for this, slip coefficient S (Equations 2.8, 2.9) 




= 𝜓 = 𝑆 − 𝜙 tan𝛽+      (2.8) 
 
𝑆 = 𝜓 + 𝜙tan𝛽+ = 0.515 + 0.115 tan 22.50°		 = 		0.563      (2.9) 
 
Applying the slip coefficient, predicted “actual” fluid velocity and angle 
values at the impeller discharge were calculated, including the actual tangential 
velocity, Cu2′, total absolute velocity, C2′, absolute fluid, 𝛼2′ and blade angles, β2′ 
(Appendix A, Equations A.13 – A.16). Calculated parameter values for the 
modified discharge triangle are shown in Table 2-3. As expected, β2′ < β2, 
because the actual flow will always slip and lag behind the discharge angle of the 
blades due to the decrease in tangential velocity, Cu. For our Pediatric VAD, the 
blade discharge angle should remain β2 = 22.5°. The actual fluid discharge 
angle, 𝛼2′, will become useful in determining the velocity within the pump volute. 
To account for pre-rotation of the fluid at the blade entrance, a pre-rotation 
ratio, R1, which is the ratio of the blade pitch-per-second, P1s, to the flow 
meridional velocity, Cm1, was applied. Under ideal conditions, the velocity of the 
fluid at the impeller eye should equal Cm1, and it is assumed that the flow will 
approach the impeller entrance with essentially 0 tangential velocity (Cu1 was 
calculated as 0.002 m/sec). However, the rotation of the impeller will impart some 
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rotation to the surrounding fluid, causing the fluid to “pre-rotate” before entering 
the impeller eye, which increases the overall absolute fluid velocity (Figure 2-6).  
 
 
Figure 2-6. Impeller design constants Km1 and Km2 versus pump specific speed 
hs. Reproduced from [24] with permission. 
 
The blade pitch-per-second is the required change in the blade angle of 
attack (or pitch) corresponding to β1. Accounting for pre-rotation, β1 should be 
increased from the initially calculated Euler value to better match the actual flow 
at the impeller eye. For single inlet suction pumps, Stepanoff [24] suggests the 
use of a ratio between 1.15 and 1.25. For the Inspired Pediatric VAD, R1 = 1.20 
was chosen to solve the modified inlet velocity triangle (Figure 2-3D). Applying 
the pre-rotation ratio, predicted “actual” fluid velocity and angle values at the 
impeller entrance can be calculated, including the actual tangential velocity, Cu1′, 
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total absolute velocity, C1′. and blade entrance angle, β1′ (Appendix A, 
Equations A.17 – A.20) (Table 2-3). 
 
Table 2-3. All calculated parameter values for the modified entrance and 
discharge Euler velocity triangles accounting for flow pre-rotation and 
slip for the Inspired Pediatric VAD impeller. 
Modified Blade Entrance Triangle Modified Blade Discharge Triangle 
Blade Pitch Per Second P1s  (m/sec) 1.44 Actual Tangential Velocity 
Cu2′  
(m/sec) 3.14 
Actual Tangential Velocity Cu1′  (m/sec) 0.35 





















2.6 Plot Impeller Blade Shape 
Pfleiderer [25] demonstrated that the optimum number of impeller blades, 
Z, for a given design can be estimated using Equations 2.10 and 2.11, which for 







				= 				31.25°    (2.10) 
  
𝑍 = 6.5 G$LG+
G$NG+
sin 𝛽; = 	6.5
+O.>L0
+O.>N0




The number of impeller blades directly impacts the level of flow 
recirculation and subsequent losses between the blades (as well as flow slip). 
Increasing the number of impeller blades will decrease the amount of flow 
recirculation, but too many impeller blades will lead to other efficiency losses due 
to flow restriction [31]. Choosing the correct number of blades is a critical 
parameter for the design. Qian et al. [32] showed that when backward swept 
centrifugal impeller designs with between 5 and 7 blades were analyzed, an 
impeller containing 6 blades achieved the lowest level of hemolysis. 
Kyparissis et al. [33] demonstrated how to plot the curve of an impeller 
blade in two-dimensions using a simple-arc method (SAM). One arc acting as the 
blade mean line is drawn between the pump inlet and outlet diameters between 
points A and C (Figure 2-7A). An auxiliary circle Ca with diameter d1 is drawn in 
the center of the impeller plot (Equation 2.12). Line E is then drawn intersecting 
point A and tangent to circle Ca. Line E has length R, which is the radius of the 
mean blade arc (Equation 2.13).  
 



















P$/.(	##$ Q RST ++.2°	N	P
2	##
$ Q RST >$°
= 8.956	𝑚𝑚  (2.13) 
 
For our Pediatric VAD, SAM was plotted (Figure 2-7B and C) and a three-
dimensional model of these values was constructed (Figure 2-7D).  
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With the preliminary blade dimensions and shape set, a method to 
evaluate the design, as well as the blade entrance and discharge heights (b1 and 
b2), was used to calculate the cross-sectional flow area at the impeller entrance 
















= 			8.378	𝑚𝑚+    (2.15) 
 
The ratio of entrance and discharge flow areas (a2 / a1) is directly related 
to the impeller hydraulic efficiency. A smooth transition between areas helps 
maintain a high hydraulic efficiency and traditionally an area ratio close to unity, 
between 1 and 1.3, is optimum [34]. For the Inspired Pediatric VAD impeller 
design, a2 / a1 = 1.7. By increasing the entrance blade height b1 from 2mm to 
3mm, the entrance and discharge flow areas will be almost equal (a2 / a1 = 1). 
However, Curtas et al. [35] demonstrated that for miniaturized pumps with low 
specific speed, larger discharge areas (a2 / a1 > 1) lead to reduced meridional 
fluid velocity Cm2 at the exit, and in turn, generated a higher acheivable pump 
head. For the initial Inspired Pediatric VAD impeller design, the inlet and outlet 
blade heights will remain as calculated (b1 = 2mm, b2 = 1mm), but modification of 






Figure 2-7.  (A) Representation of the mean blade line plotted using the simple-
arc method (SAM), reproduced from [33] with permission, (B) Plot of 
the mean blade line for the Inspired Pediatric VAD impeller, (C) Plot 
of all six mean blade lines for the Inspired Pediatric VAD impeller 
with dimensioned entrance and exit angles, (D) Three-dimensional 
solid model of the basic Inspired Pediatric VAD impeller features. 
 
2.7 Impeller Blade Thickness and Profiling 
Acheivable blade thickness (e) is typically determined by the 
manufacturing process of the impeller and mechanical requirements (forces) of 
the blades. The Inspired Pediatric VAD impeller will be produced using injection 
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molding of a biocompatable polycarbonate polymer and a blade thickness of 
around 1mm will be the smallest achievable dimension. According to traditional 
theory, blade thickness should be as small as possible to ensure that the desired 
flow lines are achieved [36]; all calculations of the flow leading up this point in our 
design have assumed a blade with zero thickness (i.e. a thin line). Shigemitsu et 
al. [37] demonstrated that acheivable pump head and efficiency increased with 
the decrease in blade thickness for a miniature centrifugal pump with six 
backward swept blades. Conversly, Kim et al. [38] showed that an impeller with 
unusually thick blades provided increased efficiency and reduced hemolysis, 
though this was determined to be more of a factor of the blade tip clearance than 
the blade thickness itself. For the preliminary design, the Inspired Pediatric VAD 
will have blades with a continuous thickness of 1mm. 
Profiling the leading and trailing edges of the blades is also critical to 
maintaining the desired flow lines and angles. For Inspired impeller, the leading 
edge was profiled with a uniform elipse along the mean line of the blade (Figure 
2-8A) to ensure favorable flow and pressure distributions [31]. The trailing edge 
was profiled with a non-uniform elipse and was filed on the suction side of the 
blade, known as under-filing (Figure 2-8A). This helps to decelerate the flow on 
the suction side of the blade tip which subsequently increases the achievable 
pump head [31], [39]. All calculated critical parameters for the initial Inspired 




Figure 2-8.  (A) Detailed view of impeller blade shape, thickness, and tip 
profiling, (B) Rendering of the final Inspired Pediatric VAD impeller 
concept with details including the impeller shroud, impeller blades, 
rotor body, rotor magnetics, and rotor body center opening. 
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Table 2-4.  All critical calculated impeller dimensions for the Inspired Pediatric 
VAD. 
 
Inspired Pediatric VAD Calculated Impeller Dimensions 
Parameter Symbol Units Value 
Impeller Inner/Eye diameter  D1 mm 8.00 
Impeller Outer Diameter D2 mm 27.40 
Estimated Rotational Speed at 
Design Point N RPM 4255.00 
Blade Inlet Angle  β1' ° 40.00 
Blade Outlet Angle  β2 ° 22.50 
Blade Inlet Height b1 mm 2.00 
Blade Outlet Height b2 mm 1.00 
Blade Thickness  e mm 1.00 
Estimated Blade Number Z blades 6.00 
Blade Mean Curve Radius  R mm 8.92 
Impeller Head Coefficient Ψ          0.52 
Impeller Flow Coefficient φ          0.12 
Speed Number 𝜎  0.12 
Diameter Number 𝛿  7.89 
Specific Speed ηs  1019.50 
 
2.8 Additional Impeller Features 
To finish the preliminary impeller design, additional features were added 
including a rotor body below the impeller blades, a shroud on top of the impeller 
blades, and a center flow opening in the middle of the rotor body (Figure 2-8B). 
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The rotor body was added to house the magnetic components needed for the 
MagLev motor system, approximately 12 mm in height below the impeller.   
A blade shroud was added, resulting in a “closed” impeller design, to help 
reduce the amount of flow recirculation and leakage from blade to blade and 
increase overall hydraulic efficiency [40]. However the shroud can induce 
retrograde flow between the shroud top surface and the top surface of the pump 
housing [41], which can be a benefit by increasing surface washing of these 
areas to reduce risk of thrombus formation but it can also lead to decreased 
efficiency and increased flow pre-rotation at the impeller eye. Special attention 
will need to be considered at this area when designing the pump housing and 
volute to ensure the optimal axial gap between the impeller shroud and upper 
housing.  
The center opening in the rotor body was added to act as a “balancing 
hole” to reduce the amount of axial thrust, or lift, produced by the impeller when 
rotating [36]. Adding the central opening simplifies the MagLev motor design 
because the motor will have less of a need to counter the axial force of the 
impeller to keep it centered in the flow channel, resulting in less power 
consumption. Additionally, the central opening will increase the flow around the 
rotor body surface, eliminating flow stagnancy between the rotor body and pump 
housing with increased surface washing and the potential to reduce thrombus 
formation [42]. However, this secondary flow channel, similar to that caused by 
the impeller shroud, may lead to increased flow recirculation within the pump and 
a decrease in overall hydraulic efficiency [28]. Special consideration in designing 
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the radial gap between the rotor body and pump housing will be applied to 




The goal of this manuscript is to present step-by-step procedures used in 
designing the centrifugal pump impeller for the Inspired Pediatric VAD by 
applying well-established traditional pump theory. The procedures and example 
calculations were used to create an initial impeller design for the Inspired 
Pediatric VAD but may also be applied to the general design of other centrifugal 
pump impellers. Essential considerations for how to design the critical 
dimensions for the impeller blades were presented, for which a functional 
impeller for the Inspired Pediatric VAD was successfully developed. The 
development methods described in this article are only the beginning in a long 
and complex process in designing radial blood pumps. The next development 
steps include the calculation and design of the pump volute, pump casing 
including all radial and axial gaps and clearances, and pump inlet and outlet 
conduits. After all initial geometries are determined, the hydraulic performance 
and hemocompatibility of the pump design will be rigorously evaluated using 
CFD predictions and prototype experiments. The data and lessons learned from 
these next stages will inform iterative design changes and improvements.  
We intend to report in future communications the next steps to fully 
characterize the Pediatric VAD performance experimentally using in vitro (mock 
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flow loop) and in vivo (ovine) models. In applying this approach, we were able to 
design a novel pediatric pump impeller as the next step in the development 
process toward fulfilling our long-term goal of achieving design freeze of a clinical 
grade device to treat a pediatric population in desperate need of temporary (30-
day) extracorporeal MCS therapy. A parallel effort has been undertaken to 
develop the universal controller that will drive the pediatric pump. The next step 
is to combine the two components to demonstrate and assess the performance 






















CHAPTER 3 : DESIGN AND COMPUTATIONAL 
EVALUATION OF A PEDIATRIC 
MAGLEV ROTARY BLOOD 
PUMP 
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3.1 Introduction 
In this article, we discuss the initial conceptual design and computational 
predictions for a new mechanical circulatory support option; the Inspired 
Universal MagLev System and the Inspired Pediatric VAD. The vision for this 
system is a universal controller/motor which can be paired with many different 
single-use pump heads for up to 30-days of circulatory or potential respiratory 
support. The development goals for the system are to make a product that is 
smaller and lower-cost than current offerings clinically in use and is self-
contained to allow for patient ambulation during treatment. 
Pediatric heart failure (HF) patients have historically been an underserved 
population with few technological advancements successfully translated into 
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clinical practice. The combination of 17% mortality for pediatric HF patients listed 
for heart transplantation [11] and limited alternative treatment options, has led to 
the emergence of mechanical circulatory support (MCS) an important modality 
for improving survival and maintaining growth and development in pediatric 
patients awaiting transplantation [9]. Unfortunately, development of suitable MCS 
devices for pediatric patients has been severely limited due to a variety of 
engineering and socioeconomic barriers. Creating a one-size-fits-all device is 
inadequate due to the wide variation in patient size and age, multiple congenital 
malformations and etiologies of cardiomyopathy, and the overall lack of data 
identifying the needs of the pediatric HF population [43]. 
Current ventricular assist devices (VADs) feature radial or axial impeller 
designs to provide high-output continuous blood flow (CF) for the adult HF 
patient population [44]. Despite increasing clinical demand, the development and 
clinical translation of pediatric-specific CF VADs has been limited. Surgeons 
often resort to using commercially available adult VADs, such as the HeartWare 
HVAD or Abbott Heartmate 3, to fill this void, but the mismatch of adult device 
requirements versus pediatric patient needs has raised the potential for clinically 
significant adverse events (thrombus formation and neurological events) at 
unacceptable rates [45]. Extracorporeal VADs represent an excellent option for 
pediatric patients since the size and clinical needs of these patients can vary 
widely. External devices allow flexibility to implement a wide range of circulatory 
support without the need for invasive surgery. Current extracorporeal VADs used 
for pediatric support include the Berlin Heart EXCOR, Medtronic Bio-Pump BP-
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50, Maquet RotaFlow, Medos Deltastream DP3, and the Thoratec 
CentriMag/PediMag systems [46]. A comparison of the design features of these  
pumps including their limitations is summarized in Table 3-1. 
 
Table 3-1.  Summary of design features of the Inspired Pediatric VAD compared 
to current commercially available pediatric extracorporeal VADs: 
Berlin Heart EXCOR, Medtronic Bio-Pump BP-50, Maquet RotaFlow, 
Medos Deltastream DP3 and Thoratec PediMag. 
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To meet the clinical needs of the pediatric patient population, Inspired 
Therapeutics (Merritt Island, FL) and the University of Louisville (Louisville, KY) 
have worked to identify and overcome potential limitations associated with 
extracorporeal VADs with the goal to incorporate significant engineering 
improvements to enhance the quality of life for these patients and their 
caretakers. We are developing a universal magnetically levitated (MagLev) 
extracorporeal pumping system, the Inspired Universal MagLev System (Figure 
3-1), to address multiple indications for use (systemic circulatory support and 
potential respiratory support) for the entire HF patient population (neonate, 
pediatric and adult). The system is based on a single, universal controller paired 
with a MagLev motor. Single-use pump heads for different indications for use can 
be installed in the universal controller and motor to address a variety of needs 
(left and right heart support, ECMO, bypass, etc.) (Figure 3-2). This modular 
approach may offer a significant advancement over existing devices and will 
focus on the development of pumps (single-use pump heads) specific to each 
population and indication. The approach offers potential benefits including the 
reduction of human error by enabling healthcare providers to train on a single 
system, allow patient ambulation on an extracorporeal device, a decreased 
recovery time, and a reduction in the overall cost of care. Advantages of the 
Inspired System are summarized in Table 1-1. 
This article focuses on the development of the first single-use pump head 
for this system, the Inspired Pediatric VAD. The pump head is specifically 
designed to address the needs of pediatric patients with diseases such as 
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cardiomyopathy, myocarditis, and congenital malformations. The goals for the 
device are to provide high flow (3.5 L/min) with a low priming volume (9.5 mL) 
and, when coupled with the Universal MagLev System, a small, compact form 
factor with the potential to be battery-powered and wearable. This article also 
outlines the criteria used to define the design input requirements for the Inspired 
 
Figure 3-1. Components of the Thoratec CentriMag/PediMag system (pump, 
motor, controller) (Top) (with dimensions shown), compared to the 
Inspired Pediatric VAD and Universal MagLev System (Bottom) 
(with goal dimensions shown). The Inspired Universal System 
combines all extracorporeal components into one small, universal 
package allowing for potential greater ease of use, quality of care, 




Pediatric VAD (flows and pressures), details the methods and processes used to 
design two versions of the pump impeller and housing (Pump V1 and an 
improved version, Pump V2), and describes the methods used to confirm both 




Figure 3-2. Basic components of the Inspired Universal MagLev system and 




3.2.1 Design Criteria 
The Inspired Pediatric VAD is intended for use in neonate and pediatric 
patients weighing up to 40 kg. Commercially available adult pumps have been 
shown to function adequately for older pediatric patients with weights exceeding 
40 kg which served as the rationale for our focus on patients below this 
threshold. Healthy pediatric blood pressures can range from (1) 85/37 mmHg 
(systolic/diastolic) for average weight of 10 kg at 1-year to (2) 106/62 mmHg for 
average weight of 40 kg at 12 years [54]–[57]. Patients with hypertension can 
experience systolic pressures between 110 and 135 mmHg in this weight range 
[54]. Cardiac outputs for healthy pediatric patients range from 1.5 to 4.0 L/min 
[57], [58]. Based upon these criteria, the Pediatric VAD is designed to provide 
0.5-3.5 L/min of continuous flow at pressures up to 150 mmHg to achieve 
adequate end organ perfusion (Table 3-3).  
 
Table 3-2.  Summary of proposed Inspired Pediatric VAD operational and design 
criteria. 
Criteria Value 
Pressure (mmHg) ≤ 150 
Flow Rate (L/min) 0.5 – 3.5 
Rotational Speed (RPM) 500 – 6000 
Rotor Diameter (mm) 27.4 




The diameter of the pump impeller/rotor is a critical parameter in achieving 
the desired flow (3.5 L/min) and performance at the pressure upper limit (150 
mmHg). A nominal impeller outside diameter of 27.4 mm was selected based on 
the desire for the pump to be significantly smaller, more compact, and 
hydraulically efficient compared to currently available pediatric extracorporeal, 
rotary pumps: BP-50, Rotaflow, and PediMag use larger diameter impellers of 79 
mm, 49 mm, and 32.5 mm, respectively. Impeller diameter was selected to 
enable a rotor magnet diameter of 1 inch (25.4 mm) and a plastic casing 
surrounding the magnet with 1 mm thick walls, to provide a 15% reduction in 
diameter and a 30% reduction in priming volume compared to the PediMag pump 
(Table 3-1). Inlet and outlet port barb sizes of ¼ inch were chosen based on 
currently available pediatric cannula sizes [59], [60]. 
 
3.2.2 Calculations for Impeller Design 
Dimensional analysis methods were used to determine impeller 
dimensions at the desired peak operating point, where maximum desired flow 
rate, Q, at pressure, ΔP, is achieved. For the previously derived design criteria, 
this point is at a flow rate of Q = 3.5 L/min at a pressure of ΔP = 150 mmHg with 
a 27.4 mm diameter impeller. The design methods of Cordier [23] were used to 
estimate the rotational speed of the impeller at 4255 RPM at the desired 
operating point.  
The dimensions of the impeller blades were calculated using the design 
methods of Stepanoff [36] and by using Euler velocity triangles (triangles formed 
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by the velocity vectors of the impeller blades and fluid) to determine the blade 
inlet and outlet angles (β1, β2), fluid meridional and tangential velocities, and 
blade inlet (b1) and outlet heights (b2), as well as the eye diameter (inner 
diameter) of the impeller (D1). Hydraulic efficiency (ηH) was calculated based on 





                           (3.1) 
 
3.2.3 Computational Fluid Dynamics Analysis 
Computational fluid dynamics (CFD) analysis techniques were used to 
evaluate and confirm the impeller and pump designs (V1, V2). Based on all 
calculated parameters, three-dimensional geometries (impeller and pump casing) 
were generated using commercial computer aided design (CAD) software 
(SolidWorks 2019, Dassault Systèmes, Waltham, MA). The inlet and outlet of the 
pump casing geometry were capped (virtually sealed off) to establish the 
computational fluid volume, which included pump inlet and outlet ports, pump 
volute, and all surfaces of the impeller. The pump geometry was transferred into 
SolidWorks Flow Simulation, a parametric flow simulation tool (FloEFD, Siemens, 
Munich, Germany) that applies the finite volume method [61] to solve the three-
dimensional Navier-Stokes equations [62]. Boundary conditions were set for the 
simulation as follows: flow velocity with parabolic profile at pump inlet, static 
pressure at pump outlet, and a real-wall stator condition (no-slip) for all pump 
casing walls. A rotating region was defined surrounding the pump impeller and 
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the sliding-mesh method was used [63]. Blood was defined as a Newtonian fluid 
with a density of 𝜌 = 1003 kg/m3 at 37° C and a viscosity of μ = 0.0035 Pa-s. 
Although blood is considered a non-Newtonian fluid, it is shear thinning, and at 
the high shear rates (>100/s) typically found in rotary blood pumps, it behaves as 
an incompressible Newtonian fluid [64]. Therefore it is appropriate to model blood 
as a Newtonian fluid with acceptance of this assumption supported by other 
related CFD studies [65]–[67].  
Reynolds numbers (Re) were calculated [68], [69] for the pump inlet and 
impellers (V1, V2) to determine if turbulent flow could be expected (Appendix B, 
Table B-1). All calculated Reynolds numbers for the impellers were in the 
laminar flow range. The calculated Reynolds number for the pump inlet was in 
the laminar-to-turbulent transition area (2300<Re<4000) [70], which is commonly 
found in modeling centrifugal blood pumps [69]. Based on similar methods 
employed by others [53], [67], and to reduce complexity of the simulation, steady 
laminar flow was simulated in all cases.  
The pump geometry was meshed using the structured Cartesian 
immersed-body method that is unique to SolidWorks Flow Simulation. This 
method differs from the traditional body-fitted meshing methods in that solid and 
fluid areas can exist within the same mesh cell, which helps minimize the overall 
mesh cell count and reduces computational time. A mesh independence analysis 
was conducted for each pump design (V1, V2) using four different meshing 
schemes with increasing levels of cell refinement at Q = 3.5 L/min and n = 4255 
RPM. Convergence goals ΔP (generated pressure) and impeller torque were 
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used to evaluate the strength of each meshing scheme (Appendix B, Table B-2 
and Figures B-1, B-2). Meshing Scheme 3 showed less than a 1% difference in 
converged ΔP value and less than a 3% difference in converged torque value 
compared to the much denser meshing Scheme 4 for both Pump V1 and V2. 
Therefore, meshing Scheme 3 was used for V1 (484,712 cells) and V2 (317,965 
cells) as a balanced compromise between calculation accuracy and mesh 
simplicity. All cases were run as time-dependent, transient simulations. Average 
inlet and outlet pressures and velocity as well as average torque (in the rotating 
axis) of the impeller were used as convergence goals, with a convergence metric 
of 2% acceptance criteria. All simulations used a variable time-step to a physical 
flow time of 0.25 seconds or until all goals were sufficiently converged. 
  
3.3 Results 
3.3.1 Impeller Dimensions 
The core components of the Inspired Pediatric VAD include the pump 
housing with inlet and outlet ports, rotor body and magnet, and the impeller 
mounted on top of the rotor body. The impeller/rotor body assembly is 
magnetically levitated, rotates within the pump housing, and is designed to 
protect against contact of the impeller with the housing or external motor. The 
initial design for the Pediatric VAD impeller (Pump V1) employs a 6-blade 
impeller with backward swept blades and an 8 mm eye diameter (impeller center 
hole). A central opening was added to the middle of the rotor body, below the 
impeller, to act as a secondary blood flow path for washing of the rotor and 
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impeller surfaces to help reduce thrombus formation. The central opening and 
secondary flow path also serve to counteract lift forces generated by the thrust of 
the impeller during rotation to keep the impeller/rotor body assembly centered 
inside the pump housing and prevent axial contact. A shroud was added to the 
top of the impeller blades to improve hydraulic efficiency. A summary of 
calculated impeller dimensions is listed in Table 3-4. The dimensions for Pump 
V2 are identical to V1 (Table 3-4), except for increased blade height (Blade Inlet 
Height b1 = 4.00 mm, Blade Outlet Height b2 = 2.00 mm). The height of the 
blades was increased based upon initial CFD findings that demonstrated Pump 
V1 failed to achieve desired performance metrics (Table 3-5). A center post in 
the bottom of the pump housing was added to Pump V2, which consumes much 
of the volume of the center opening through the rotor body to create a more 
uniform flow path, and reduces the priming volume from 9.5 mL (V1) to 9.0 mL 
(V2). Blade tip extensions (2.5 mm) were also added to Pump V2 to increase the 
achievable pressure. Comparisons of the three-dimensional solid models of the 






Pump V1 - Calculated Impeller Dimensions 
Parameter Symbol Units Value 
Impeller Inner/Eye diameter  D1 mm 8.00 
Impeller Outer Diameter D2 mm 27.40 
Estimated Rotational Speed at Design 
Point N RPM 4255.00 
Rotor Height H1 mm 12.00 
Blade Inlet Angle  β1' ° 40.00 
Blade Outlet Angle  β2 ° 22.50 
Blade Inlet Height b1 mm 2.00 
Blade Outlet Height b2 mm 1.00 
Blade Thickness  Su mm 1.00 
Estimated Blade Number Z blades 6.00 
Blade Mean Curve Radius  R mm 8.92 
Impeller Head Coefficient Ψ          0.52 
Impeller Flow Coefficient φ          0.12 
Speed Number 𝜎  0.12 
Diameter Number 𝛿  7.99 
Specific Speed ηs  1019.49 
Volute Throat Area Ath mm2 25.45 
Volute Base Circle D3 mm 29.92 




3.3.2 Pump Performance 
Pump V1 and V2 designs were unable to achieve the target flow rate (Q = 
3.5 L/min) at the target pressure (ΔP = 150 mmHg) for the estimated rotational 
speed (n = 4255 RPM); However, both pump designs were able to reach the 
desired pressure at higher rotational speeds. Preliminary analysis showed that 
Pumps V1 and V2 achieved a ΔP of 91 mmHg and 120 mmHg respectively, at n= 
 
Figure 3-3. Cross section views of the 3D geometry of Pump V1 (V1 A) 
compared to Pump V2 (V2 A). View of the 3D geometry of the 
impeller for Pump V1 (V1 B) and Pump V2 (V2 B), looking from the 
bottom upward to see detail of the blades beneath the shroud. 
Highlighted impeller and pump features include the shroud, inlet 




4255 RPM (Table 3-5). Pump V2 achieved an increase of 30% in pressure 
compared to Pump V1 at the simulation point with a slight increase in overall 
hydraulic efficiency (~1.5%). 
 
Table 3-4. Summary of converged values pressure (ΔP) and torque and 
calculated hydraulic efficiency (ηH) for Pumps V1 and V2 at Q = 3.5 
L/min and n = 4255 RPM. 
 
 
3.3.3 Pump Pressure Distribution 
Pressure distributions for pumps V1 and V2 at the simulation point, Q = 
3.5 L/min and n = 4255 RPM are shown in Figure 3-4 for planar cut through the 
center of the pump inflow (V1A, V2A), planar cut through the impeller blades 
(V1B, V2B), and three-dimensional isometric views of the pressure distribution 
on the outer surfaces of the pump housings (V1C, V2C). The static pressure at 
the outlet held steady at 150 mmHg for both simulations. Pump V2 achieved 
lower pressures at the pump inlet and generated a larger pressure (ΔP) 
compared to Pump V1. 
 ΔP (mmHg) Torque (N-mm) ηH  Hydraulic Efficiency (%) 
Pump V1 90.80 5.79 27.37 





3.3.4 Pump Flow Distribution 
The velocity flow fields for Pumps V1 and V2 at the simulation point are 
shown in Figure 3-5 with planar cut view through the middle of the blades (V1A) 
and through the middle of the impeller blade extensions (V2A). Pump V1 failed to 
create a uniform flow field within the pump volute and also experienced flow 
separation at the transition of the volute to the pump outlet (also called the cut-
water). Pump V2 created a relatively uniform flow distribution within the volute 
 
Figure 3-4. For Q = 3.5 L/min and n = 4255 RPM, (V1 A) Pressure distribution 
planar to inlet center of V1, (V1 B) Pressure distribution through 
impeller blades of V1, (V1 C) Isometric view of pressure distribution 
at outer housing surfaces of V1, (V2 A) Pressure distribution planar 
to inlet center of V2, (V2 B) Pressure distribution through impeller 
blades of V2, (V2 C) Isometric view of pressure distribution at outer 
housing surfaces of V2. 
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likely due to the blade extensions and increased blade height. Three-dimensional 
velocity flow fields are shown at a planar cut through the center of the pump 
inflow (V1B, V2B). In both pumps, the flow enters the eye of the impeller 
uniformly before turning perpendicularly into the passages between the blades. 
No significant vortices were observed in the blade passages for either Pump V1 
or V2. There are three distinct flow paths for Pumps V1 and Pump V2: (1) a 
primary path where flow enters the impeller eye, travels through the blades and 
into the volute, and exits at the pump outlet (Figure 3-5 V1B, shown with white 
arrows); (2) a secondary flow path down around the outside of the rotor housing 
and then up through the center opening of the rotor housing (Figure 3-5 V1 B, 
shown with grey arrows); and (3) secondary flow at the top of the impeller shroud 
and the top of the pump housing where flow reverses and travels back toward 
the jet flow at the pump inlet (Figure 3-5 V1 B, shown with purple arrows). The 
secondary flow path at the top of the pump housing is minimal for Pumps V1 and 
V2 and only occurs close to the pump housing surface. The secondary path 
around the rotor body is quite different for Pump V1 compared to V2 due to the 
addition of the center post in V2. In Pump V1, there is strong flow close to the 
inner surface of the rotor body center opening, which provides good surface 
washing, but the flow concentrated in the middle of the center opening is random 




Figure 3-5. For Q = 3.5 L/min and n = 4255 RPM, (V1 A) Velocity flow fields at a 
planar surface cut through the center of the impeller blades for 
Pump V1, (V2 A) velocity flow fields at a planar surface cut through 
the center of the impeller blades extensions for Pump V2, (V1 B) 
three dimensional velocity flow fields planar to inlet center for Pump 
V1 with highlighted flow paths; primary (white arrows), rotor 
secondary (grey arrows), pump housing secondary (purple arrows), 




post in Pump V2, and the tight 0.5mm gap between the rotor body and the center 
post, the flow velocity is strong along both the rotor body and center post 
surfaces. 
 
3.3.5 Wall Shear Stress 
Wall shear stress (WSS) surface plots for the pump impeller and pump 
housing surfaces are shown in Figure 3-6 for pumps V1 and V2 at the simulation 
point, Q = 3.5 L/min and n = 4255 RPM. Areas on the surfaces that experience 
WSS greater than 150 Pa are highlighted in red. Shear stresses between 150 – 
250 Pa with flow exposure times of 102 seconds have been shown to cause 
hemolysis of red blood cells [71]. The highlighted areas for both Pump V1 and V2 
are minimal but there are still some unavoidable concentration points, especially 
at the impeller blade exit and impeller blade extensions, that should be 
investigated further in future hemolysis studies. Additionally, all though the center 
post found in Pump V2 greatly improves the velocity flow field of the blood in this 
region, it appears to cause a concentration of high shear stress not found on 
Pump V1. This will be investigated further in future studies. Mean WSS values for 
both Pump V1 and V2 can be found in Appendix B, Table B-3. 
 
3.3.6 Increased Rotational Speed 
CFD simulations were also conducted for Pumps V1 and V2 at higher 
rotational speeds of 4500, 5000, 5500, and 6000 RPM in an attempt to achieve 
the design point ΔP = 150 mmHg, Q = 3.5 L/min with resulting pressures (Figure 
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3-7A) and hydraulic efficiencies (Figure 3-7B) over the range of rotational 
speeds presented. Pump V1 was able to achieve 150 mmHg between 5000 – 
5500 RPM, with a maximum pressure of 230 mmHg at 6000 RPM. Pump V2 was 
able to achieve 150 mmHg between 4500 - 5000 RPM, with a maximum 
pressure of 279 mmHg at 6000 RPM. Pumps V1 and V2 achieved their 
 
Figure 3-6. Surface plots of Pump V1 and V2 pump housings and impellers 
indicating areas where wall shear stress (WSS) values exceed 150 
Pa at Q = 3.5 L/min and n = 4255 RPM. 
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maximum efficiency point for Q = 3.5 L/min at 5000 RPM with an efficiency of 
30% for V1 and 29% for V2. Pressure distributions for Pump V2 at a planar cut 
through the middle of the impeller blade extensions are shown in Figure 3-8. As 
expected, the pressure distributions within the pump and impeller increase with 
higher gradients with increasing rotational speed.  
 
Figure 3-7. (A) Plotted generated pressure (ΔP) versus rotational speed (n) at Q 
= 3.5 L/min for Pumps V1 and V2, (B) Plotted calculated hydraulic 
efficiencies (ηH) versus rotational speed (n) at Q = 3.5 L/min for 




Figure 3-8. Pressure distributions at a planar surface cut through the middle of 
the impeller blade extensions for Pump V2 at Q = 3.5 L/min and (A) 






The Inspired Pediatric VAD was successfully designed, modeled, and 
virtually simulated to produce the desired peak operating conditions by achieving 
a flow of 3.5 L/min at 150 mmHg. Pump V2 was able to produce higher 
pressures than Pump V1 (20% to 30% increase) at all simulated rotational 
speeds, and the design reduced the priming volume to 9 mL (5% reduction). 
Pump V1 and V2 designs were able to produce clean velocity distributions 
through the impeller blades and relatively uniform pressure distributions at the 
initial rotational speed n = 4255. Pump V1 did not produce a uniform velocity 
distribution within the volute, which may be attributed to the small blade outlet 
height (1mm) in relation to the volute throat diameter (5.7mm), and also 
experienced flow separation at the volute cut-water. Pump V1 also experienced 
non-uniform flow within the center opening of the rotor body at n = 4255 RPM. 
The addition of the blade tip extensions, increased blade height, and a center 
post in Pump V2 appear to have resolved these limitations. Pumps V1 and V2 
required operation at higher rotational speeds to achieve the desired pressure 
(ΔP = 150 mmHg).  
The Inspired Pediatric VAD achieved a maximum hydraulic efficiency for 
Q = 3.5 L/min at 5000 RPM for both Pump designs. Pump V1 exhibited slightly 
higher efficiencies compared to Pump V2 at all rotational speeds, except at 4255 
RPM, even though V2 produced much higher pressures. These results were 
anticipated since the hydraulic efficiency is inversely proportional to the impeller 
torque, and Pump V2 design included impeller blade extension with larger 
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momentum arm, thereby generating greater torque. The typical calculation to 
determine hydraulic efficiency is to divide the fluid power (Q x ΔP) by the input 
power of the motor driving the impeller. For this study, impeller torque was 
derived from the CFD simulation by summing the torque experienced by all 
impeller surface faces. While this method provides an estimate of the current 
efficiencies, the true values will be revealed once a motor power term can be 
determined from physical prototypes. Simulations predict Pumps V1 and V2 will 
compare favorably to other VADs in the desired flow range. The Inspired 
Pediatric VAD may achieve 30% efficiency, which compares favorably to the DP3 
at 27.5 % (3.5 L/min, 150 mmHg) [50], Rotaflow at 26% (3.5 L/min, 150 mmHg) 
[50], and PediMag at 37% (3.5 L/min, unknown pressure) efficiencies [72]. 
Though the initial findings from this study are promising, the CFD 
simulations of the pump designs only offer predictions of its potential 
performance. These CFD predictions must now be validated by testing a physical 
prototype of the pump in a mock circulatory loop utilizing a blood analogue 
glycerol-water solution as well as whole blood. The initial flow field predictions 
from the CFD in this study are also promising, but to fully characterize these, 
further CFD simulations need to be conducted with a more in-depth look at flow 
leakage and retrograde flow around the impeller (which causes hydraulic losses) 
as well as formation of vortices inside the impeller blade passage and at the 
blade exit. These new CFD studies will be validated through particle image 
velocimetry (PIV) experiments of a pump prototype. Lastly, the hemodynamic 
performance of the pump and impeller designs will need to be evaluated through 
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CFD hemolysis predictions and hemolysis flow loop experiments. Evaluating the 
hemolysis rates in this device will be critical in determining any areas of the 
impeller or pump geometry that may need further design modifications. 
Advanced design features of the Inspired Universal System may offer 
functional, operational, and technological advantages compared to other 
currently available extracorporeal VADs including the EXCOR, BP-50, RotaFlow, 
DP3, and PediMag. The EXCOR and PediMag devices represent the only 
options specifically designed for pediatric patients. The EXCOR requires use of a 
large external console and is pneumatically driven. The system operates in a 
pulsatile mode and uses a polymeric membrane and a pair of polymer valves [47] 
both of which are susceptible to fatigue. The EXCOR device has been 
associated with limited long-term use and durability [48]. The PediMag is a 
miniaturized continuous flow centrifugal pump that uses MagLev technology to 
drive a suspended impeller. The PediMag device is only approved for low flows 
(1.5 L/min) and short-term use (6 hours), though it is often used for longer 
durations [73], and requires a large bed-side coupled motor and controller unit 
[74] that does not allow patients to ambulate during treatment. The BP-50, 
RotaFlow, and DP3 are rotary continuous flow pumps that use magnetic coupling 
rather than true MagLev to rotate the impeller around a physical bearing. The 
Inspired Pediatric VAD will employ a contactless bearing design coupled with the 
MagLev technology to levitate and rotate the impeller rotor. In contrast, in 
magnetic coupling the impeller/rotor is still anchored by a physical bearing, 
 
 60 
creating a concentrated point for mechanical wear, heat generation, and blood 
damage [17], [18]. 
 
3.5 Conclusion 
Throughout this conceptual phase of research and development of the 
Inspired Universal MagLev System, the objective has been to design and 
evaluate a next generation extracorporeal MCS system for pediatric patients 
suffering from cardiopulmonary disorders. The design goal has been to develop a 
modular system capable of providing adequate hemodynamic support in a form 
factor that is smaller, more portable (wearable) and intuitive to use for caretakers 
responsible for managing the wellbeing of pediatric patients.  
This study serves as the first of a series of articles that will describe the 
engineering effort to develop the Inspired System. The initial focus has been on 
the design phase for the Inspired Pediatric VAD with an attempt to introduce 
multiple novel features compared to commercially available pumps while also 
demonstrating that the resulting design met product development requirements. 
Subsequent articles will describe the fabrication and testing of the VAD 
prototype, design and testing of the MagLev motor, and in vitro and in vivo 
studies that evaluate the safety and performance of the Inspired Universal 
System.  
The pediatric heart failure population remains in dire need of a dedicated 
MCS solution, for which the entire HF community may benefit from a compact, 
low-cost MCS option that can be adapted to fit individual patient needs. Our goal 
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is to produce future single use, 30-day modules to provide respiratory assistance 
with a potential module that will include an integrated pump/oxygenator that 
could greatly reduce the size of a traditional ECMO circuit. The hope will be to 
design the system to allow a patient suffering from severe respiratory dysfunction 
to be ambulatory. If this system were available today with the COVID-19 
pandemic, there would likely be widespread adoption of the technology.  
In summary, the preliminary hydrodynamic data generated thus far for the 
Inspired Pediatric VAD have been encouraging. The next phase of development 
will focus on characterization, human factors engineering, and verification that 









CHAPTER 4 : DEVELOPMENT OF INSPIRED 
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IMPELLER TORQUES AND 
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4.1 Preface 
Pediatric heart failure (HF) patients have historically been an underserved 
population and have the highest mortality rate at 17% of any population awaiting 
heart transplantation [11]. Due to this great clinical need, Inspired Therapeutics 
(Merritt Island, FL) and the University of Louisville (Louisville, KY) have been 
developing the Inspired Pediatric VAD, a rotary blood pump to be used with the 
Inspired Universal MagLev System. As seen in Table 3-2, the vision for this 
system is a universal controller/motor which can be paired with a variety of 
different single-use pumps for different indications for use (neonate, pediatric and 
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adult) providing up to 30-days of circulatory or respiratory support. The 
development goals for the system are to produce a product that is smaller, less 
expensive, and wearable to allow for patient ambulation during treatment. The 
impeller and pump design concepts for the Pediatric VAD have been previously 
described by the authors [22]. The next phase in the development process 
focuses on the design of the novel MagLev motor that will be integrated into the 
Universal MagLev System to levitate and rotate the Pediatric VAD impeller/rotor. 
This article describes the methodology and presents the results of computational 
fluid dynamics (CFD) model simulations and in vitro testing (static mock flow loop 
model) to characterize pump pressure and flow performance and hydraulic 
torques and translational forces acting on the pump impeller/motor. These results 
will be used to complete the design of the novel MagLev motor. 
 
4.2 Introduction 
Motor designs for rotary blood pumps (RBP) have many unique 
requirements. Not only do these motors need to be compact and demonstrate 
long-term reliability, they also require relatively large gaps between rotor and 
stator components (compared to traditional motors) to accommodate channels 
for adequate blood flow and the use of contactless bearings to prevent blood 
damage [75]. Modern RBPs typically use electric motors with an external motor 
stator, pump housing, internal rotating element (typically a combination impeller 
and motor rotor), and bearings to allow for rotation and impeller/rotor stability 
(Figure 4-1). The driving portion of the motor that rotates the impeller/rotor is 
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achieved using a combination of permanent- and electromagnets, which may 
also serve to levitate the impeller/rotor within the pump casing.  
To stabilize the impeller/rotor and provide a point of rotation, several RBP 
designs, including the Medtronic BioPump BP-50, Maquet RotaFlow, and Medos 
Deltastream DP3, use a shaft and mechanical bearing attached to the center of 
the rotor [18], [49], [51]. Although these designs use small bearings with minimal 
contact, they create a concentrated point for mechanical wear, heat generation, 
noise, vibration, and a potential risk for clinically significant blood damage [76]. 
Modern designs have employed contactless bearings using permanent or 
electromagnetics between the rotor and stator or hydrodynamic bearings as is 
the case of the HeartWare HVAD [77], which provide improved hemodynamics 
that show promise in helping to reduce the risk of blood damage [78]. A unique 
design used in the Thoratec HeartMate3 and Levitronix CentriMag systems is 
based on a “bearingless slice motor”, which combines the motor and bearing into 
a single component [79], [80]. Irrespective of their novel design and orientation, 
all rotary blood pump motors must be hemocompatible, generate sufficient torque 
to rotate the impeller/rotor, and provide translational forces to stabilize the 
rotation of the impeller/rotor. Motor designs may also be unique to each pump 
type, including different sized diameter impeller/rotors and operational ranges 
(pressures and flows) for the intended patient populations. This variance in 
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geometries and operational parameters may directly impact the torques and 
forces the motor may be required to produce.  
 
The proposed motor design for the Inspired Pediatric VAD is a MagLev 
system that completely levitates and rotates the pump impeller/rotor in a manner 
that eliminates physical contact between parts. The impeller/rotor is levitated 
 
Figure 4-1. Exploded view of the Inspired Pediatric VAD concept detailing the 
fluid flow direction, impeller rotational direction (Z-axis), impeller 
translational force directions (X, Y, Z-axis) and the pump 
components; the Upper Pump Housing, Impeller, Motor Rotor, 
Lower Pump Housing, and Motor Stator. 
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within the pump housing, providing a blood gap of 0.5 mm around the sides and 
0.75 mm at the bottom of the rotor, with a total gap of approximately 2 mm 
between rotor and stator magnetic components (Figure 4-2). With these 
dimensions in place, the performance of the pump impeller/rotor and surrounding 
fluid within the pump requires characterization over the anticipated operational 
 
Figure 4-2. Cut-view of the Inspired Pediatric VAD concept detailing the 
blood/fluid gap between the impeller/rotor and pump housing (0.5 
mm along sides, 0.75 mm along bottom) and the overall gap (2 mm) 




range of the pump to define the design requirements for the MagLev motor. The 
motor performance characteristics include the required torque to rotate the 
impeller and propel the fluid (rotation about the Z-axis), the axial lift force 
(translation in the Z-axis) generated by the impeller acting on the fluid, and the 
hydrodynamic forces from the surrounding fluid acting on the impeller/rotor in the 
tangential, radial, and axial directions (X, Y, and Z-axis, respectively) (Figure 4-
1). In this article, we present in vitro testing of an Inspired Pediatric VAD pump 
and the CFD model simulations used to quantify and define these critical system 
design parameters.  
  
4.3 Methods 
4.3.1 Prototype Construction 
A prototype of the Inspired Pediatric VAD was constructed to quantify the 
required magnitude and range of impeller hydraulic torques and to benchmark 
hydrodynamic performance. This test device was assembled using a shaft to 
rotate the pump impeller in place of the future MagLev motor and bench tested in 
a static flow loop (SFL, Figure 4-3 A,B,C). This simplified shaft driven prototype 
allowed testing of critical parameters (pump performance, impeller torque) which 
will translate into engineering requirements to complete the MagLev motor 
design. The lower pump housing, impeller, and upper pump housing were 
fabricated using additive manufacturing techniques that meet design 
specifications in accordance with the defined geometries calculated using 
computational models, as previously described [22]. The components were 
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printed using stereolithography with a proprietary high-resolution ABS-like clear 
material (WaterShed XC). The impeller was fabricated without a center opening 
in the rotor body to allow coupling of an 8 mm diameter shaft to be driven by a 
permanent magnet DC motor. The pump assembly was mounted on a custom 
fixture with the DC motor at the base. A nitrile rubber double-lip seal was added 
to the lower pump housing as a leak-proof entry for the DC motor shaft. The shaft 
was permanently attached to the center of the impeller/rotor and coupled to the 
 
Figure 4-3. (A) Side and (B) Top views of the prototype of the Inspired Pediatric 
VAD including SLA polymer impeller, lower pump housing, and 8mm 
metal shaft. (C) VAD prototype attached to custom fixture with 
coupled DC motor and tachometer, which are connected to the (D) 







DC motor shaft via a mechanical coupler. This attachment mechanism was also 
used to set the height of the impeller within the pump housing to maintain the 
fluid/blood gaps between the impeller and housing. A laser-based tachometer 
(PLT200, Monarch Instrument, Amherst, NH) was used to measure the rotational 
speed of the shaft and impeller. 
 
4.3.2 Determination of Impeller Hydraulic Torque 
A permanent magnet DC (PMDC) motor (12V/24V 3000/6000rpm, Guang 
Wan Motor Co, LTD.) powered by a variable DC power supply (PS280, 
Tektronix, Beaverton, OR) was used to rotate the VAD impeller. The motor 
current and supply voltage were measured with a pair of digital multimeters 
(Fluke 45, Fluke Corporation, Everett, WA). Additionally, this motor was used to 
determine the magnitude of hydraulic torque, 𝛕Hydro, (torque due to circulating 
fluid) acting on the impeller over a range of rotational speeds (500 - 6000 RPM) 
and pressures (ΔP, 0 to ~420 mmHg) using the following protocol. First, an 
average implied motor torque constant (Kt) was determined for the motor to 
calculate the torque (𝛕) based on motor current (I), (Equation 4.1) [81].  
 
𝜏 = 𝐾Y × 𝐼     (4.1) 
 
This measurement was obtained using another DC motor to back-drive 
the PMDC motor over a range of rotational speeds (400 to 7500 RPM). At each 
speed, the voltage generated by the motor was recorded (Appendix C, Table C-
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1), and an average back electromotive force (EMF) constant for the motor was 
determined (Ke, Equation 4.2). By converting the units, the average back EMF 









𝑀𝑜𝑡𝑜𝑟	𝐶𝑢𝑟𝑟𝑒𝑛𝑡	(𝐼)}    (4.3) 
 
𝐾? = 𝐾Y     (4.4) 
 
The calculated values were Ke = 3.311 V/kRPM and Kt = 31.57 N*mm/A. 
The PMDC motor was then operated using the variable power supply over the 
range of rotational speeds against no load. Motor voltage and current were 
recorded at each rotational speed in 500 RPM increments. The total torque (𝛕DC) 
generated by the DC motor alone was then calculated at each rotational speed 
(Appendix C, Table C-2) defined as the product of the motor current (I) and Kt. 
The calculated torque was plotted against rotational speed (Appendix C, Figure 
C-1), and a corresponding linear curve of best fit was obtained. The associated 
linear equation (Equation 4.5) (R2=0.9839) was used to generate a secondary 
equation to calculate the total torque of the DC motor (𝛕DC) at any rotational 
speed (ω), including the motor viscous damping coefficient (Bm) and the kinetic 




𝑦 = 0.7948𝑥 + 6.8301	 → 	 𝜏GH = (𝐵; × 𝜔) + 𝑇Z;  (4.5) 
 
The total PMDC motor torque represents the base torque of the system, 
and any generated torque above PMDC motor torque would be due to friction 
losses from the shaft and pump housing seal and hydraulic forces acting against 
the impeller. To determine the torque losses due to friction of the shaft and seal 
(𝛕Friction), the PMDC motor was coupled to the Pediatric VAD impeller through the 
center shaft and placed on the testing rig. The Pediatric VAD was not filled with 
fluid. The PMDC motor was operated over a range of rotational speeds (1000 
RPM increments) and the motor voltage and current were recorded at each 
speed to calculate the total torque of the dry system (𝛕Total, Dry) (Appendix C, 
Table C-3). The average torque due to friction and other losses (𝛕Friction) of the 
shaft and seal was calculated based on the difference between the total torque of 
the dry system (𝛕Total, Dry) and the total torque of the DC motor (𝛕DC), (Equation 
4.6).  
 
𝜏	[B<@Y<\= = 𝜏]\YC^,GB` − 𝜏GH     (4.6) 
 
The total torque (𝛕Total) and impeller hydraulic torque (𝛕Hydro) of the pump 




4.3.3 Static Flow Loop (SFL) Model Testing 
A static flow loop (SFL) model consisting of a fluid reservoir, compliant 
silicone tubing, and a screw-type clamp (to adjust flow resistance) was 
constructed (Figure 4-3D). The fluid reservoir was submerged in a heated water 
bath with a thermoregulator unit (Techne TE-10D, Cole-Parmer, Vernon Hills, IL) 
to maintain temperature at 37° C. The Inspired Pediatric VAD was inserted in-line 
with the SFL circulation. High-fidelity pressure transducers (MPR-500, Millar, 
Houston, TX) were placed at the pump inlet (P2) and outlet (P1), and a transit-
time flow probe (6XL, Transonic, Ithaca, NY) at the pump outlet (VAD Flow). The 
SFL was filled with one liter of a blood analogue solution consisting of a saline-
glycerol mixture with 3.6 cP viscosity (equivalent to the viscosity of 38% 
hematocrit blood [83], [84]). A 10 ml sample of the solution was tested using a 
calibrated Cannon-Fenske style viscometer submerged in a 37° C water bath to 
quantify the measured density of the sample (1.1096 g/ml with a viscosity of 3.66 
cP). 
The hydrodynamic performance of the Pediatric VAD was tested across 
the range of rotational speeds (500 – 6000 RPM) via the following protocol. The 
voltage of the DC power supply was adjusted to produce a VAD impeller 
rotational speed starting at 500 RPM, confirmed by the tachometer. With the 
resistance clamp completely open (no load), the pump inlet and outlet pressures, 
flow rate, and the motor voltage and current were measured at the set rotational 
speed. This condition provided the maximum flow rate of the pump against 
minimum resistance (ΔP = 0 mmHg) at the set rotational speed. The resistance 
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clamp was then tightened to lower the pump flow rate at specified increments 
(0.15, 0.20, or 0.25 L/min, depending on rotational speed setting). At each 
incremental pump flow rate, all parameters were recorded. The resistance clamp 
was also tightened to fully occlude the system, resulting in a pump flow rate of 0 
L/min and providing the maximum pressure of the pump at the set rotational 
speed. The system was reset with the resistance clamp completely opened, and 
this process was repeated for increasing rotational speeds (500 to 6000 RPM at 
500 RPM increments). Experimental data for all test conditions were collected at 
a sampling rate of 400Hz using PowerLab 16/35 (ADInstruments, Sydney, 
Australia) and recorded by LabChart 8 (ADInstruments, Sydney, Australia) data 
acquisition system software. 
The total torque (𝛕Total) of the Inspired Pediatric VAD prototype at each 
speed and flow setting was calculated using the measured motor current (I) and 
the derived torque constant (Kt). The hydraulic torque (𝛕Hydro) of the impeller was 
based on the net torque between the calculated total torque (𝛕Total) of the fluid 
filled system, the total base torque of the DC motor (𝛕DC) calculated with the 
derived linear equation, and the calculated average torque due to friction of the 
shaft and seal (𝛕Friction), (Equation 4.7).  
 




4.3.4 Computational Fluid Dynamics (CFD) Model Simulations 
A series of CFD simulations were conducted to confirm the Inspired 
Pediatric VAD hydrodynamic performance and hydraulic torque values found 
empirically using the SFL model. A three-dimensional geometry (impeller and 
pump casing) of the VAD was generated using commercial computer aided 
design (CAD) software (SolidWorks 2019, Dassault Systèmes, Waltham, MA). 
The inlet and outlet of the pump casing geometry were capped (virtually sealed 
off) to establish the computational fluid volume, which included pump inlet and 
outlet ports, pump volute, and all surfaces of the impeller. The pump geometry 
was transferred into SolidWorks Flow Simulation, a parametric flow simulation 
tool (FloEFD, Siemens, Munich, Germany) that applies the finite volume method 
[61] to solve the three-dimensional Navier-Stokes equations [62], and meshed 
using the structured Cartesian immersed-body method. A rotating region was 
defined surrounding the pump impeller and the sliding-mesh method was used 
[63]. Blood was defined as a Newtonian fluid with a density of 𝜌 = 1060 kg/m3 at 
37° C and a viscosity of μ = 0.0035 Pa-s [64], [66], [67]. All cases were run as 
time-dependent, transient simulations. Average inlet and outlet pressures and 
velocity as well as average torque (in the rotating axis) of the impeller and X, Y, 
and Z translational forces (summation of forces acting on all impeller body 
surfaces) were used as convergence goals, with a convergence metric of 2% 
acceptance criteria. All simulations used a variable time-step to a physical flow 
time of 0.50 seconds or until all goals were sufficiently converged. 
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The initial CFD simulation (Setup 1) (Figure 4-4A, B) for the Inspired 
Pediatric VAD included a mesh size of 317,965 cells with boundary conditions: 
flow velocity with fully developed parabolic profile at pump inlet, static pressure at 
pump outlet (100 mmHg), and a real-wall stator condition (no-slip) for all pump 
casing walls. Based on deviation of initial results from CFD Setup 1 compared to 
 
Figure 4-4. (A) Computational fluid volumes for CFD simulation Setup 1 and 2, 
(B) CFD Setup 1, Front and Top plane cut-plots of flow velocity for 
5000 RPM at 3.00 L/min, (C) CFD Setup 2, Front and Top plane cut-
plots of flow velocity for 5000 RPM at 3.00 L/min. 
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empirical results from the SFL, an additional CFD simulation (Setup 2) was 
constructed to try to improve CFD predictions. CFD Setup 2 extended the inlet 
and outlet ports of the pump by 50 mm each and included a mesh size of 
430,950 cells with boundary conditions: flow velocity with fully developed 
parabolic profile at pump outlet, environmental pressure at pump inlet (100 
mmHg initial pressure), and a real-wall stator condition (no-slip) for all pump 
casing walls (Figure 4-4A, C). The flow velocity boundary condition was moved 
to the pump outlet in Setup 2 in an attempt to allow the flow at the pump inlet to 
fully develop naturally and not impart any assumed flow velocity field on the inlet 
of the impeller. Simulations using both Setups 1 and 2 were conducted at each 
test condition to produce pump pressure (ΔP), impeller torque, and impeller 
forces (X, Y, Z vectors) for each rotational speed and flow rate. An overview of 
SFL and CFD model experiments are presented in Figure 4-5. 
 
Figure 4-5. A flow chart detailing the SFL (using the empirical pump prototype, 
EXP) and CFD (using Setup 1 and 2) experiments, the tested pump 
conditions (rotational speed or flow rate and rotational speed) for 
each experiment, and the collected variables for each experiment 





4.4.1 Empirical Pressure-Flow Curves 
With the flow rates (Q) and pressures (ΔP) from the SFL model, the full 
hydrodynamic performance of the Inspired Pediatric VAD was observed for the 
first time over the operational range (500 – 6000 RPM) of the pump. These 
results were plotted to form characteristic pressure-flow curves (HQ curves) for 
the pump (Figure 4-6). The Inspired Pediatric VAD (prototype) was able to 
achieve flow rates as high as 4.27 L/min with pressures as high as 422 mmHg at 
6000 RPM. 
 
Figure 4-6. Characteristic HQ curves (pressure versus flow rate) for the Inspired 





4.4.2 Empirical Torque Curves 
The calculated hydraulic torques acting on the VAD impeller were plotted 
versus the pump flow rates producing characteristic torque curves for the pump 
(Figure 4-7). Over the operational flow range of the pump (0.5 – 3.5 L/min), 
required torques to propel the fluid in the range of 0.97 to 15.56 mNm were 
observed. Torques at the lower rotational range of the pump (500 – 2000 RPM) 
were low (<1 mNm), with occasional negative values calculated due to the tare 
calculation (subtracting average friction and DC motor torque) to determine the 
hydraulic torque. 
 
Figure 4-7. Hydraulic torque of the Inspired Pediatric VAD empirical prototype 




4.4.3 Empirical vs. CFD Results 
Results from the prototype pump in the SFL compared with corresponding 
CFD simulations for Setups 1 and 2 are presented in Tables 4-1, 2, and 3. 
Simulation results for CFD Setups 1 and 2 varied, particularly at higher flow rates 
with differences as high as 19% for generated ΔP values, while generated 𝛕Hydro 
values were similar, with most values within 5% of one another for each 
simulation case. CFD Setup 2 typically produced lower overall ΔP values and 
higher force values than Setup 1. The difference between ΔP values from Setup 
1 to Setup 2 for CFD simulations produced varied results compared to the 
empirical prototype (EXP) for both ΔP and 𝛕Hydro (Figures 4-8 and 4-9). The 
slope of the HQ curves generated with CFD are flatter compared to the more 
rounded curves from the empirical prototype. The slope of the torque curves 
generated with CFD are linear as are the curves from the empirical prototype, 
increasing with increased flow rate, though CFD values differ from empirical 




Table 4-1.  Empirical results for the Inspired Pediatric VAD prototype in the SFL 
including generated pressure head (ΔP) and impeller/rotor hydraulic 
torque (𝛕Hydro) for selected rotational speed and flow cases (3000, 
4000, and 5000 RPM). U = Unachievable, meaning the flow rate was 
not achievable at the given rotational speed by the prototype pump 









EXP - Empirical Prototype in Static Flow Loop 
    Hydraulic 










(mmHg) (mNm) X Y Z 
3000 2.50 U U U U - - - 
3000 1.50 21.22 -17.44 38.66 2.94 - - - 
3000 1.00 58.73 -7.65 66.38 2.56 - - - 
3000 0.50 85.44 -0.90 86.34 2.25 - - - 
4000 3.00 U U U U - - - 
4000 2.00 55.86 -31.23 87.09 8.65 - - - 
4000 1.00 138.64 -7.23 145.87 7.61 - - - 
4000 0.50 165.10 -0.64 165.74 7.42 - - - 
5000 4.00 U U U U - - - 
5000 3.00 57.67 -65.33 123.00 11.96 - - - 
5000 2.00 168.92 -29.36 198.28 10.92 - - - 
5000 1.00 244.80 -6.91 251.71 10.38 - - - 
5000 0.50 273.43 -0.20 273.63 9.78 - - - 
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Table 4-2.  CFD results for simulation Setup 1 including generated pressure 
head (ΔP) and impeller/rotor hydraulic torque (𝛕Hydro) for selected 
rotational speed and flow cases (3000, 4000, and 5000 RPM) and 
translational force values for the impeller/rotor in the x, y, and z 
directions. 
CFD1 – Setup 1 
    Hydraulic  











(mmHg) (mNm) X Y Z 
3000 2.50 100.00 41.38 58.62 4.43 0.10 0.24 0.62 
3000 1.50 100.00 32.27 67.73 4.03 0.07 0.22 0.28 
3000 1.00 100.00 28.90 71.10 3.67 0.11 0.11 0.12 
3000 0.50 100.00 27.48 72.52 3.46 0.07 0.02 0.01 
4000 3.00 100.00 -16.28 116.28 7.02 0.18 0.39 0.96 
4000 2.00 100.00 -26.30 126.30 6.36 0.19 0.24 0.53 
4000 1.00 100.00 -31.10 131.10 5.95 0.08 0.16 0.27 
4000 0.50 100.00 -40.77 140.77 5.63 0.02 0.11 0.07 
5000 4.00 100.00 -80.90 180.90 10.52 0.36 0.50 1.61 
5000 3.00 100.00 -99.17 199.17 9.82 -0.70 0.63 1.22 
5000 2.00 100.00 -102.91 202.91 8.96 0.15 0.13 0.46 
5000 1.00 100.00 -117.80 217.80 7.96 0.16 0.11 0.30 
5000 0.50 100.00 -124.85 224.85 7.70 0.00 0.47 0.31 







Table 4-3.  CFD results for simulation Setup 2 including generated pressure 
head (ΔP) and impeller/rotor hydraulic torque (𝛕Hydro) for selected 
rotational speed and flow cases (3000, 4000, and 5000 RPM) and 
translational force values for the impeller/rotor in the x, y, and z 
directions. 
  
CFD2 – Setup 2 
    Hydraulic  











(mmHg) (mNm) X Y Z 
3000 2.50 140.45 93.11 47.34 4.46 0.12 0.28 0.78 
3000 1.50 159.85 97.52 62.33 3.91 0.08 0.24 0.52 
3000 1.00 166.26 98.90 67.36 3.76 0.05 0.20 0.39 
3000 0.50 172.03 99.72 72.31 3.38 0.05 0.11 0.24 
4000 3.00 189.61 90.06 99.55 6.90 0.25 0.35 1.22 
4000 2.00 211.24 95.59 115.65 6.30 0.13 0.29 0.84 
4000 1.00 229.17 98.90 130.27 5.85 0.14 0.23 0.52 
4000 0.50 232.73 99.72 133.01 5.30 0.12 0.14 0.49 
5000 4.00 235.96 82.36 153.60 10.49 0.39 0.56 1.85 
5000 3.00 272.88 90.09 182.79 9.51 0.26 0.42 1.39 
5000 2.00 293.48 95.60 197.88 8.89 0.24 0.25 1.01 
5000 1.00 308.18 98.89 209.29 8.02 0.16 0.20 0.80 
5000 0.50 318.43 99.72 218.71 7.24 -0.10 0.01 1.02 





Figure 4-9. HQ curves of the VAD empirical prototype versus generated curves 
from CFD simulations Setups 1 and 2 for rotational speeds 3000, 
4000, and 5000 RPM. 
 
Figure 4-8. Hydraulic torque of the VAD empirical prototype versus generated 
curves from CFD simulations Setups 1 and 2 for rotational speeds 
3000, 4000, and 5000 RPM. 
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4.4.4 Impeller Forces 
The translational hydrodynamic force values for the impeller/rotor in the x, 
y, and z vectors that were generated from the CFD simulations are plotted in 
Figure 4-10. These values were derived as the sum of all force values acting on 
each body surface of the impeller/rotor in the CFD simulations. Tangential and 
radial forces (X and Y vectors) were relatively small (0.5 N or less) for both Setup 
1 and Setup 2 for all rotational speeds. For both Setup 1 and 2, the axial force (Z 
vector) in the positive direction increased with increased rotational speed, likely 
due to the lift force created by the impeller rotation. Overall, Setup 2 produced 
greater force values in the X, Y, and Z directions than Setup 1, with typically 
increasing values as rotational speed and flow rate increased. In some cases, 
Setup 1 produced extremely varied values compared to Setup 2, particularly in 











Figure 4-10. Plots of translational X, Y, and Z-axis forces of the Inspired 
Pediatric VAD impeller/rotor generated from CFD Setups 1 and 2 at 




4.5.1 Inspired Pediatric VAD Performance 
Hydrodynamic torque values for the impeller/rotor and the pump 
performance values (pressure and flow rate) for the Inspired Pediatric VAD were 
successfully quantified empirically using a prototype device in a SFL model over 
the pump operational range (500 – 6000 RPM). Additionally, HQ curves, 
hydrodynamic impeller/rotor torque, and translational force values in the 
tangential, radial, and axial directions for the impeller/rotor were successfully 
generated using CFD for select cases (3000, 4000, 5000 RPM). The shaft-driven 
prototype was able to achieve a flow rate as high as 4.27 L/min against a 
pressure of 127 mmHg at 6000 RPM. At the VAD’s maximum intended design 
flow rate of 3.5 L/min, the pump was able to achieve pressures of 135 mmHg and 
210 mmHg at 5500 and 6000 RPM, respectively.  
These values differ from our prior CFD work [22], which predicted a flow of 
3.5 L/min was achievable at 4255 RPM at a pressure of 120 mmHg, as well as 
the CFD work done in this study (Setups 1 and 2) which predicted similar results. 
HQ curves generated via CFD Setups 1 and 2 exhibit a very flat slope, showing 
less reduction in ΔP with increased flow rate, Q, than the empirical prototype HQ 
curves, which exhibit a more rounded slope with greater ΔP fall-off as Q is 
increased. Though values between CFD and empirical hydraulic torque curves 
differed, both sets of curves followed the same trend of a linear increase in 
torque following an increase in flow rate. Attempts to improve the CFD model to 
match the empirical results with the implementation of Setup 2 were not 
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successful even though the HQ and torque curve trends between the two CFD 
Setups were similar. The CFD simulations in this study were not as accurate in 
predictions compared with the empirical findings and the CFD model needs to be 
improved to more accurately reflect actual pump performance.  
There are many potential factors that could contribute to the inaccuracy of 
the CFD predictions including modeling of the inlet and outlet tubing, potential 
differences in surface roughness and dimensions, and assumptions made with 
the CFD simulation model (see Study Limitations section). Additionally, the flow 
paths within the Inspired Pediatric VAD are very complex. In addition to the 
primary flow path through the impeller and out the pump outlet, there is a 
secondary flow path of fluid circulating around the outer perimeter of the rotor 
body and through the center opening, and a tertiary path of fluid recirculating 
between the top of the impeller shroud and upper pump housing. These flow 
paths were designed to provide washing of all pump surfaces to negate thrombus 
formation but are also detrimental to the overall hydraulic efficiency of the pump 
as not all fluid adheres to the primary impeller path, and this is common in many 
RBP designs. Although these flow paths are seen in the present CFD results the 
simulation may not be accurately modeling these flow “leakages”, causing the 
pump to perform better in simulations than in the actual prototype experiment 





4.5.2 Indications for MagLev Motor Design 
Empirical HQ and torque findings from this study provide insight into the 
design requirements for the MagLev motor system to be developed. For the 
spinning motor component, the MagLev system will need to be able to spin the 
impeller/rotor between 2000 and 5500 RPM and produce torques between 0.10 
and 14 mNm to achieve the desired pump operational range from 0.5 to 3.5 
L/min at 40 to 150 mmHg. Although translational force values were not able to be 
produced empirically in this study, and the CFD predictions differed from 
empirical findings, CFD predictions from this study will be used as an estimate for 
impeller/rotor forces until better predictions are achieved. Overall, the generated 
force values indicate that with increased rotational speed and flow rate, the 
impeller/rotor will rise upward inside the pump housing (positive Z-axis) due to 
increasing axial force and the levitation component of the MagLev system will 
have to contend with levitating not only the mass of the impeller/rotor, but also 
counteracting lift forces as high as 1.9 N produced by the impeller. 
 
4.5.3 Study Limitations 
Results from this study highlight some of the limitations related to 
computational modeling, prototype fabrication methods, and mock loop models. 
The difference in CFD and empirical results were not entirely unexpected as CFD 
simulations tend to represent a best-case scenario for pump performance with 
many assumptions made that often do not translate to physical bench testing. 
There have been many studies that have examined blood pump designs that 
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compare empirical and CFD results with varied levels of success toward 
achieving agreement between the two approaches [35], [40], [85]–[88]. Typically, 
CFD models must be customized for each pump geometry to more accurately 
match the conditions of the physical testing set-up [89]. Some assumptions in the 
CFD simulations made in this study included treating blood as a Newtonian fluid 
and assuming steady laminar flow, both of which were done to reduce simulation 
complexity and calculation time. Additionally, the pump geometry components in 
the CFD simulations were assumed to be perfectly smooth, with no surface 
variation, and the inlet and outlet ports on the pump were straight rigid tubes, 
which was not the case with SFL model testing as the pump inlet and outlet were 
connected to compliant tubing that curved in various areas. All of these 
assumptions may have contributed to differences observed between CFD model 
predictions and SFL model empirical findings. We plan to further investigate 
these challenges with continued CFD model development and comparison to in 
vitro model testing. 
Another limitation of this study is the production of pump prototype 
components via additive manufacturing. Since the Inspired Pediatric VAD is in 
early development phase, additive manufacturing was utilized to produce 
prototype components to reduce cost and allow for rapid changes in component 
design. Unfortunately, the accuracy of the impeller blade geometry and pump 
housing volute produced by 3D printing may have varied from the solid model 
used in the CFD simulations due to printing tolerances [90]. The SLA printing 
tolerances using the WaterShed material were ±0.002 inches in the X/Y 
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dimension and ±0.005 inches in the Z dimension, not accounting for material 
shrinkage. The Pediatric VAD has many small features with typical wall 
thicknesses around 0.020 inches, so accuracy is key to produce these 
dimensions. Additionally, SLA printed plastics are not perfectly smooth, creating 
surfaces with roughness between 2 – 4 µm [91]. In future studies we will utilize 
high fidelity measuring techniques and systems to inspect pump components 
against CFD solid models. 
Lastly, hydraulic torque of the impeller/rotor in the SFL experiment was not 
measured (i.e. with a dedicated torque transducer), but was calculated via the 
PMDC motor, which may affect the accuracy. Although these methods each have 
limitations, CFD and bench-top models represent two practical techniques that 
can be used to efficiently design blood pumps and together provide useful 
information to make informed design decisions.  
Despite these limitations, this research resulted in data that suggests the 
Inspired Pediatric VAD will be able to generate the desired pressures and flow 
rates to provide adequate circulatory support for pediatric heart failure patients. 
These empirical performance results obtained in this study compare favorably to 
other blood pumps used in the pediatric population including the BP-50, 
RotaFlow, Deltastream DP3, and Thoratec PediMag [18], [49], [51], [53]. A 
comparison of the torque and force data generated by this study to other blood 
pumps is difficult since these values are directly determined by the pump’s 
impeller/rotor diameter and size as well as hydrodynamic conditions. The torque 
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and force data generated in this study will be instrumental in designing the 
specific MagLev motor for the Inspired Pediatric VAD. 
 
4.5.4 Further Thoughts on CFD Predictions and Future Work 
Initial computational modeling (CFD) and proof-of-concept bench testing 
was conducted to characterize the hydrodynamic performance of the Inspired 
Pediatric VAD. As anticipated, variances between CFD model predictions and 
experimental test conditions were identified. In addition to the limitations detailed 
in the previous section, other key aspects of the CFD simulations will be 
considered to help identify design weaknesses and engineering challenges, 
which will be a focus of improvement with future development work.  
Accurate and sufficient discretization (meshing) of the Pediatric VAD 
model is critical to achieving accurate numerical simulation predictions. In using 
the Sliding Mesh Method [63] in SolidWorks Flow Simulation, there are multiple 
ways to define the three-dimensional rotating region that encompasses the 
impeller/rotor body that may affect the meshing at this critical boundary. The 
immersed body structured meshing method used in SolidWorks Flow Simulation 
initiates the meshing process by creating a global mesh of the entire simulation 
geometry. This mesh is then refined (cells are broken into finer cells for 
increased resolution) by the user to identify key areas of interest, where the 
geometry is complex, or where complicated flow conditions (i.e. vortices, 
turbulence, etc.) are predicted to occur. In addition to refining the global mesh, 
local meshes of key geometries, surfaces, or fluid regions may also be created.  
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Two local meshes were defined in this study, one surrounding all 
impeller/rotor surfaces, and a second specifically at the pump housing walls in 
the radial blood gap between rotor and housing. These two local meshes had 
increased refinement in addition to the refinement of the global mesh to ensure 
that the discretization of the fluid volume at the critical area between the rotating 
region and stationary pump wall was sufficient (adequate resolution). Further, a 
mesh independence analysis was conducted for the Inspired Pediatric VAD V2 
using four different levels of local and global mesh refinement at the Q = 3.5 
L/min and n = 4255 RPM test condition. Convergence goals ΔP (generated 
pressure) and impeller torque were used to evaluate the strength of each 
meshing scheme (Appendix B, Table B-2 and Figures B-1, B-2). Meshing 
Scheme 3 showed less than a 1% difference in converged ΔP value and less 
than a 3% difference in converged torque value compared to the much finer 
meshing with Scheme 4. Therefore, meshing Scheme 3 was used for CFD Setup 
1 (317,965 cells) and CFD Setup 2 (430,950 cells); however, continued 
assessment of mesh refinement is warranted given the observed variances 
between predicted and empirical findings. In future work, different geometries will 
be used to define the rotational region surrounding the impeller/rotor resulting in 
variances to the mesh and mesh refinement at the critical radial gap. Additional 
simulations will be performed in a parametric fashion to observe the effect of 
different geometry definition and meshing techniques at this critical area. 
An additional CFD simulation (Setup 2) was conducted to observe the 
effect of the length of the pump inlet and outlet ports on the measured average 
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static pressure at each of the inlet/outlet boundaries. In CFD Setup 1 (shorter 
inlet/outlet ports), a parabolic velocity profile was defined at the inlet boundary to 
simulate fully developed flow into the pump. In CFD Setup 2, a parabolic profile 
was not initially defined, and during the simulation, a parabolic velocity profile 
was created “naturally” due to the extended length of the inlet tube. The working 
hypothesis was that the “artificial” velocity profile used in Setup 1 may have led to 
incorrect numerical predictions at the simulation boundaries. After completing 
multiple simulations with both setups, the inlet/outlet length and parabolic velocity 
profile were found to have little effect on the predicted outcome (less than 10% 
difference for most predictions). This finding suggests that meshing appears to 
be a critical aspect in attaining accurate predictions in SolidWorks Flow 
Simulation. Therefore, the CFD model will continue to be modified to improve the 
meshing of the Pediatric VAD model in future studies.  
Laminar flow was assumed in this study to reduce the computational load 
of each simulation and in the calculation of the predicted flow conditions within 
the Pediatric VAD. Reynolds numbers (Re) were calculated for the pump inlet 
and impeller regions of the VAD geometry following methods suggested by 
Fraser et al. [68], [69] for predicting flow conditions for centrifugal blood pumps 
(Table B-1 and Table E-1). The decision to model strictly laminar flow was made 
based on the Reynolds number predictions and also after reviewing many similar 
studies where laminar flow was modeled for pediatric centrifugal pumps [53], 
[67]. Based upon the results of VAD V2 simulation and bench testing, the 
Inspired Pediatric VAD was re-designed with a new VAD geometry (VAD V3). 
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CFD simulations of VAD V3 design were conducted using laminar and turbulent 
solvers in SolidWorks Flow Simulation to compare results between the two 
methods (Appendix F). For these simulations, blood was assumed to be a 
Newtonian fluid. The two solvers produced varied results for predicted ΔP and 
impeller torque values (5 – 15% difference for all predicted values, Table F-1, 
Figure F-1). However, the slopes of predicted HQ curves using the two methods 
were almost identical (slope of -9.1 for Laminar solver vs. -11.3 for Turbulent 
solver), suggesting that there is merely an offset in predicted values between the 
two methods rather than a disagreement between the overall CFD simulations 
(average offset of 20.6 ± 3.6 mmHg). In future work, the effects of turbulent flow 
will be investigated, which may be better modeled using a more robust turbulent 
flow solver (ANSYS Fluent). 
In SolidWorks Flow Simulation, convergence of the simulation solution is 
determined by assessing integrated quantities from the solution, such as average 
flow rate and average static/total pressure, for which these user-defined values 
are selected as “Goals”. In other CFD software, convergence is often measured 
by observing changes in the residuals of the Navier-Stokes conservation of 
momentum and energy equations. Goal quantities in SolidWorks tend to function 
in a similar fashion to solution residuals, and criteria are generally set to 
determine convergence based on changes in the Goal quantities (e.g. when the 
solution is converged, Goal quantities should have limited changes, if any, to 
their values).  
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Goal quantities of flow rate, velocity, and average static pressure at both 
the inlet and outlet boundaries were used in this study, with strict convergence 
criteria (less than a 2% change in Goal value). For all simulations, the Goal 
quantities typically converged within the first 0.10 to 0.15 seconds of physical 
flow time, which was observed in the curve plots of the Goal values vs. Time and 
the Goal convergence criteria (changes of less than 2% in the Goal solution 
value between iterations). All simulations were run to a physical flow time of 0.5 
seconds. In addition to Goal convergence criteria, adequate time step values 
were used for each simulation (detailed in Appendix B.1). In future work, the 
effect of time step and Goal convergence criteria on the accuracy of the CFD 
numerical predictions will be used as an additional metric for comparison to the 
prototype experimental findings will be investigated. 
 
4.6 Conclusion 
While our previously reported work focused on the initial design of the 
Inspired Pediatric VAD, this article focused on the design of the novel MagLev 
motor for the Inspired Universal system. The data acquired in this investigation 
will be instrumental in advancing the design of the MagLev motor to ensure that it 
is able to produce adequate torque to drive the impeller/rotor, translational forces 
to stabilize the impeller/rotor, and responsiveness to accurately position the 
impeller/rotor within the pump housing at all times. Future work will include the 
design, fabrication, and testing of the MagLev motor and controller for the 
Inspired Universal MagLev system with pre-clinical testing in mock flow loop and 
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large animal models. The concept of the Inspired System as a universal platform 
for multiple pumps is extremely innovative and coupled with the fully magnetically 
levitated impeller/rotor design of the Pediatric VAD (and all future VADs), this 
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5.1 Introduction 
In the United States, 14,000 children are hospitalized with heart failure 
(HF) and HF-related conditions each year, with an overall mortality rate of 7% 
[10]. The population of pediatric patients listed for heart transplantation (HT) 
continues to grow with approximately 600 new listings each year while the 
population of donor organs remains static [92], [93]. With limited treatment 
options, mechanical circulatory support (MCS) has emerged as an important 
modality for improving survival and maintaining growth and development in 
pediatric patients [9]. Unfortunately, the development of suitable MCS devices for 
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pediatric patients has fallen far behind the efforts for the adult population. To 
address this clinical need, Inspired Therapeutics (Merritt Island, FL) and the 
University of Louisville (Louisville, KY) have been developing the Inspired 
Pediatric VAD, a new single-use rotary blood pump for use with the Inspired 
Universal MagLev System that is being designed to provide up to 30-days of 
circulatory support for pediatric heart failure patients (Figure 5-1).  
The unique concept of the Inspired System is to enable clinicians to treat 
many different indications for use (cardiopulmonary bypass, HF, respiratory 
 
Figure 5-1. Exploded view of the Inspired Pediatric VAD V3 (left) identifying the 
rotating body (impeller, rotor body, and rotor magnetics) and the 
stationary body (upper and lower pump housing), and conceptual 
rendering of the complete Inspired Universal MagLev System with 
attached Inspired Pediatric VAD (right) identifying the motor 
housing, universal controller module with battery hook-ups, and the 
VAD inlet holder cap, which holds the impeller/rotor in a stationary 
position for transport. 
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assist) and patient populations (neonate, pediatric, adult) using one common, 
compact, universal motor/controller to power and drive an array of modular 
disposable pumps. The initial development for this system focused on the 
pediatric pump (Inspired Pediatric VAD), for which the design, computational fluid 
dynamics (CFD) analysis, and in vitro testing of the impeller and pump housing 
have been previously described [22]. The resulting data were applied in the 
development of a novel magnetically levitated (MagLev) motor system that freely 
levitates and rotates the pump impeller/rotor. Subsequently, the prototype 
Inspired Pediatric VAD was redesigned to accommodate the MagLev system 
components. In this article, we describe the computational characterization of the 
newest iteration of the Inspired Pediatric pump (VAD V3) and detail its predicted 
hydrodynamic performance compared to earlier prototypes (VAD V1, VAD V2). 
Additionally, we detail the complicated velocity flow fields present in the new design and 
the predicted hemocompatibility through shear stress and residence time analysis. 
 
5.2 Methods 
5.2.1 Inspired Pediatric VAD V3 Design 
The initial design of the Inspired Pediatric VAD impeller, rotor body and 
pump housing were created before the development of the MagLev motor 
system. The prototypes (V1, V2) were initially designed with a single magnetic 
component inside the rotor body below the impeller (Figure 5-2, Inspired 
Pediatric VAD V2). The VAD impeller/rotor hydrodynamic torques and forces for 
these prototypes were characterized and used to develop the MagLev motor. 
Specifically, the MagLev motor design required lengthening the lower pump 
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housing and rotor body to accommodate the rotor magnetics. Additionally, due to 
molding requirements, wall thicknesses of the lower pump housing and rotor 
body needed to be adjusted to maintain the gap between rotor and stator 
components and the blood gap between impeller/rotor and housing. A center 
post in the lower pump housing, which the impeller/rotor rotated around in VAD 
V2, was also removed due to molding requirements, leaving a center opening in 
 
Figure 5-2. Comparison of the Inspired pediatric VAD V2 (top left) and V3 
(bottom right) illustrating differences in rotor body and pump 
housing design, which resulted in an increase in priming volume 
from 9.1 to 14.5 ml, and removal of the center post (V3). 
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the rotor body. The re-design (Figure 5-2) resulted in a unique rotary blood pump 
geometry with a long rotor body and an increase in priming volume from 9.1 ml 
(V2) to 14.5 ml (V3).  
 
5.2.2 MagLev Motor Design 
The MagLev motor development required creating a combined electric 
motor and magnetic levitation system that would allow the impeller/rotor of the 
VAD to remain suspended and rotating in the blood without contacting the pump 
housing walls over a range of speeds (500 – 6000 RPM), pressures (up to 150 
mmHg), and flows (0.5 – 3.5 L/min). Passive static magnetics were selected for 
the radial bearing system with active levitation in the axial direction. Since 
complete static/passive stable magnetic levitation is not possible in all three 
dimensions (x, y , z-axis) [94], a voice coil magnetic actuator (VCA) was selected 
to actively control the axial position (levitation) of the floating/rotating assembly of 
components. The VCA is part of a position feedback system that senses the axial 
position of the floating impeller/rotor assembly using Hall effect sensors and 
varies the current in the VCA coil to produce an axial magnetic force that in turn 
controls the impeller/rotor position. Active axial positioning of the pump 
impeller/rotor is a novel aspect of the Inspired System, and the controller allows 
for precise positioning of the moving member and maintenance of axial blood 
gaps. Previous MagLev blood pumps such as the Thoratec CentriMag system 
use passive axial positioning with active radial positioning, which allows the 
impeller/rotor to rise and fall within the pump housing with changes in rotational 
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speed, flow, and system pulsatility. Changes in the axial blood gap can cause the 
formation of vortices that are detrimental to pump efficiency and 
hemocompatibility [95], and in the case of the CentriMag, increasing the axial 
blood gap increases the fluid shear stress and residence time and the lift force 
generated by the rotating impeller [96]. A slotless brushless DC motor that met all 
 
Figure 5-3. Cross-section view of the MagLev motor design for V3 showing 
rotor and stator components and identifying the passive magnetic 




of the torque-speed operating requirements was developed to rotate the actively 
levitated impeller/rotor. A passive magnetic bearing (PMB) system was designed 
to control the radial positioning of the impeller/rotor within the pump housing, 
maintaining the necessary blood gaps around the perimeter of the rotor. A cross-
section of the MagLev motor design V3 is illustrated in Figure 5-3.  
 
5.2.3 Computational Fluid Dynamics (CFD) Simulation 
Computational fluid dynamics (CFD) analysis techniques were used to 
evaluate the hydrodynamic performance, impeller/rotor torques and forces, and 
hemocompatibility of the redesigned Inspired Pediatric VAD V3. Three-
dimensional geometry (impeller and pump casing) was generated using 
commercial computer aided design (CAD) software (SolidWorks 2019, Dassault 
Systèmes, Waltham, MA). The pump geometry was transferred into SolidWorks 
Flow Simulation, a parametric flow simulation tool (FloEFD, Siemens, Munich, 
Germany) that applies the finite volume method [61] to solve the three-
dimensional Navier-Stokes equations [62]. The computational fluid volume for the 
simulation was established, including the pump inlet and outlet ports, pump 
volute, and all surfaces of the impeller, and a rotating region was defined 
surrounding the pump impeller and the sliding-mesh method was used to 
simulate impeller rotation [63]. Boundary conditions for the simulation were set 
as: (1) fully developed parabolic profile flow velocity field at the pump inlet, (2) 
constant static pressure at the pump outlet, and (3) real-wall stator condition (no-
slip) for all pump housing walls. In previous analyses of the Inspired Pediatric 
 
 104 
VAD V2, blood was modeled as a Newtonian fluid for simplicity; however, 
SolidWorks Flow Simulation provides limited data output in terms of shear rates 
and forces in the flow domain when simulating this type of fluid. To address this 
limitation for analysis of the V3 design, blood was modeled as a Non-Newtonian 
fluid via the Power Law Model [97] with a density of 𝜌 = 1060 kg/m3 at 37° C, a 
minimum viscosity of μ = 0.003038 Pa-s, a consistency index of 0.01217 Pa-s, 
and a power-law index of 0.7991 [98]. 
To assess flow turbulence, Reynolds numbers (Re) were calculated [68], 
[69] for the pump inlet port and the impeller to determine whether turbulent flow 
may occur (Appendix E, Table E-1). All calculated Reynolds numbers for the 
impeller at the simulated rotational speeds of 3000, 4000, and 5000 RPM were in 
the laminar flow range. The calculated Reynolds numbers for the pump inlet were 
in the laminar flow range for flow rates 0.5 – 2.0 L/min and were in the laminar-to-
turbulent transition area (2300 < Re < 4000) [70] for flow rates between 2.5 – 4.0 
L/mins, as has been reported in the modeling of centrifugal blood pumps [69]. 
Based on similar methods employed by others [53], [67], and to reduce 
complexity of the simulation, steady laminar flow was simulated for all cases.  
The pump geometry was meshed using the structured Cartesian 
immersed-body method and a mesh independence analysis was conducted 
using four different meshing schemes (Appendix E, Figure E-1) with increasing 
levels of cell refinement (coarse to fine) at a flow rate of Q = 1.00 L/min and 
rotational speed of n = 3000 RPM. Convergence goals for generated pressure 
(ΔP) and impeller torque were used to evaluate the strength of each meshing 
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scheme (Appendix E, Figure E-2). Meshing Scheme 3 showed less than a 
0.50% difference in converged ΔP value and less than a 1% difference in 
converged torque value compared to the finest meshing Scheme 4. Therefore, 
meshing Scheme 3 with 1,155,126 cells was used. All cases were run as time-
dependent, transient simulations. Average inlet and outlet pressures and velocity 
as well as average torque (in the rotating axis) of the impeller and X, Y, and Z 
translational forces (summation of forces acting on all impeller body surfaces) 
were used as convergence goals with 2% acceptance criteria. All simulations 
used a variable time-step to a physical flow time of 0.50 seconds or until all goal 
targets were sufficiently converged. 
For comparative purposes, additional CFD simulations of the Inspired 
Pediatric VAD V3 were conducted assuming blood as a Newtonian fluid and 
laminar flow as well as a version of the k-ε turbulence model to solve the 
Reynolds Averaged Navier-Stokes equations [99]. These results are presented in 
the Appendix F. 
 
5.2.4 Shear Stress Analysis 
Blood damage due to flow fields within rotary blood pumps is determined 
by two factors: the magnitude of the shear stress that the blood is exposed to 
and the exposure time of the blood to this stress. Hemolysis of red blood cells 
occurs with a shear stress of 150 – 250 Pa coupled with an exposure time of 
approximately 100 seconds [71]. Additional factors to consider are the 
degradation of von Willebrand factor (vWF), which has been observed in patients 
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with continuous flow VADs [100], and the activation of platelets, which can lead 
to thrombus formation. In this study, we applied the method presented by Fraser 
et al. [68] and applied by others [101]–[103] to quantify these factors with three 
thresholds: (1) shear stress of 9 Pa for vWF degradation, (2) 50 Pa for platelet 
activation, and (3) 150 Pa for hemolysis. In SolidWorks Flow Simulation, shear 
rate for non-Newtonian liquids is defined as:  
 
?̇? = /𝑑<a





    (5.1) 
 
A scalar representative viscous shear stress (𝜏) was calculated in each 
fluid mesh cell as the product of shear rate and dynamic fluid viscosity (µ): 
 
𝜏 = 	𝜇(?̇?)     (5.2) 
 
Fluid residence time in each mesh cell was calculated as an estimate of 
blood exposure time. The size of each cell was estimated by taking the cubic root 
of the cell volume (CV) and residence time was determined by dividing the cell 
size by the velocity magnitude (v) [101]: 
 
𝑅𝑒𝑠𝑖𝑑𝑒𝑛𝑐𝑒	𝑇𝑖𝑚𝑒 = 	 √Hd
'
e
     (5.3) 
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5.2.5 Hydrodynamic Performance 
The hydrodynamic performance of the Inspired Pediatric VAD V3 was 
characterized by computationally predicting generated pressures (ΔP) for various 
flow rates (Q) 0.50 – 4.00 L/min, for three rotational speeds, 3000, 4000, and 
5000 RPM. The flow rates and predicted pressures were used to form 
characteristic pump curves (H-Q curves) and were compared to curves 
generated from computational analysis of the previous pump version VAD V2. 
 
5.3 Results and Discussion 
5.3.1 Hydrodynamic Performance 
VAD V3 was able to achieve pressures of 75 mmHg and 179 mmHg at the 
lowest operating point of 3000 RPM (0.5 L/min) and at the highest at 5000 RPM 
(4.00 L/min), respectively (Figure 5-4). The predicted pressures for VAD V2 and 
VAD V3 agreed well with less than a 3% difference between all predicted 
corresponding values. Although the rotor body and pump housing of the pump 
were redesigned for VAD V3, the design of the impeller and pump volute were 






5.3.2 Impeller Torque and Translational Forces 
With the elongation of the rotor body, the overall surface area of the 
impeller/rotor increased from 3910 mm2 for V2 to 8509 mm2 for V3. 
Subsequently, the hydrodynamic torque (along the rotational axis) acting on the 
VAD impeller/rotor significantly increased in VAD V3. Characteristic torque 
curves for VAD V2 and VAD V3 are shown in Figure 5-5. Peak torque increased 
from 10.5 mN-m for VAD V2 to 20 mN-m for VAD V3 at 5000 RPM and 4.00 




Figure 5-4. Computationally predicted characteristic pressure-flow curves (H-
Q) for Inspired VAD V2 and V3 at various rotational speeds (3000, 




Computationally predicted translational hydrodynamic force values for the 
VAD V3 impeller/rotor in the x, y, and z vectors are plotted in Figure 5-6 for 
comparison to VAD V2. These values were derived as the sum of all force values 
acting on the surface of the impeller/rotor in each CFD simulation. Tangential 
forces (X vector) were relatively small (≤ 0.5 N) and similar for VAD V2 and VAD 
V3 for all rotational speeds. The axial force (Z vector) in the positive direction 
increased with increasing rotational speed, likely due to the lift force created by 
the impeller rotation, for VAD V2 and VAD V3. VAD V3 attained equivalent or 
higher axial force values compared to VAD V2 and consistently showed higher 
axial forces across all flow rates at 5000 RPM. Maximum lift forces increased to 
 
Figure 5-5. Computationally predicted impeller/rotor hydraulic torque values for 
Inspired VAD V2 and V3 at various rotational speeds (3000, 4000, 
5000 RPM) and flow rates (0.50 – 4.00 L/min). 
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2.2 N for VAD V3 from 1.6 N for VAD V2 at 5000 RPM and 4.00 L/min. Although 
the main hydrodynamic components were unchanged between V2 and V3, 
additional lift forces may have been caused by an increase in axial blood gap 
(0.50 mm V2 to 0.75 mm V3) and the increased flow through the rotor body 
 
Figure 5-6. Plots of computationally predicted translational X, Y, and Z-axis 
forces of the Inspired Pediatric VAD V2 and V3 impeller/rotor at 
various rotational speeds (3000, 4000, 5000 RPM) and flow rates 




center opening with the absence of the center post. Differences in meshing 
schemes and/or fluid modelling between the analyses of VAD V3 and VAD V2 
may also have contributed to some discrepancies between force values. 
 
5.3.3 Pressure Distribution and Flow Fields 
Figure 5-7 shows the pressure distributions through a cross-sectional 
plane through the top of the impeller blades and the center of the pump outlet 
tube, and a sagittal plane through the center of the pump inlet tube. The 
 
Figure 5-7. Pressure distribution through the impeller blades (top) and planar to 
pump inlet center (bottom) of the Inspired Pediatric VAD V3 at 
various rotational speeds (3000, 4000, 5000 RPM) and flow rates 
(0.50, 1.00, 3.50 L/min). 
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boundary condition of a static pressure of 200 mmHg at the pump outlet was 
maintained for each simulation allowing the pressure difference at the pump inlet 
(ΔP) to be generated. VAD V3 was able to achieve a pressure of 176 mmHg 
across the pump at 5000 RPM (3.50 L/min) compared to just 75 mmHg at 3000 
RPM (0.5 L/min).  
The pressure distribution between the impeller inlet eye and the rotor body 
center opening differed in VAD V3 at higher rotational speed and flow (5000 
RPM and 3.50 L/min), with a 40 – 50 mmHg difference between the two areas. 
This differs from similar centrifugal pumps, such as the Thoratec PediMag, which 
demonstrated a uniform pressure distribution from the pump inlet through the 
impeller eye and rotor body center opening [53]. This variation may be attributed 
to the overall length of the VAD V3 rotor body compared to that of the PediMag 
or the difference in blood gap below the rotor body (VAD V3 has a much thinner 
gap). This pressure difference was not seen in the computational analysis of 
VAD V2 and may have contributed to the formation of vortices surrounding the 
rotor body in VAD V3. Two additional views of the pressure distribution at the 
pump housing surface for VAD V3 are shown in Figure 5-8.  
Figure 5-9 describes the three-dimensional velocity flow fields via cross 
sectional plots through the middle of the pump inlet across range of rotational 
speeds (3000, 4000, 5000 RPM) and flow rates (0.50, 1.00, 2.00, 3.50 L/min). At 
lower rotational speeds and flow rates, there is a significant amount of retrograde 
flow leakage and pre-rotation that extends upward into the pump inlet, which may 
be eliminated by increasing flow rate and rotational speed. At all flows and 
 
 113 
rotational speeds, a uniform vortex is created in the center opening of the rotor 
body. This differs significantly from the random flow patterns predicted for VAD 
V1, which also had a center opening within a shorter rotor body that led to the 
decision to add the center post into the opening in VAD V2 [22]. The results 
suggested that a center post may not be necessary to promote uniform return 
flow within the center opening. As was seen in VAD V2, there are three distinct 
flow paths within the pump in VAD V3: (1) a primary path where flow enters the 
impeller eye, travels through the blades and into the volute, and exits at the 
pump outlet (Figure 5-9, shown with white arrows); (2) a secondary flow path 
 
Figure 5-8. Isometric views of pressure distributions at the pump housing 
surface of Inspired Pediatric VAD V3 at various rotational speeds 




down around the outside of the rotor housing and then up through the center 
opening of the rotor housing (Figure 5-9, shown with grey arrows); and (3) 
tertiary flow at the top of the impeller shroud and the top of the pump housing 
where flow reverses and travels back toward the jet flow at the pump inlet 
(Figure 5-9, shown with purple arrows). The secondary and tertiary flow paths 
can be considered as flow leakages and are detrimental to the overall hydraulic 
efficiency of the pump, but promote favorable surface washing of all pump 























































































































































































5.3.4 Taylor Vortices 
An unexpected result of the VAD V3 redesign was the formation of super-
laminar Taylor vortices around the circumference of the elongated rotor body. In 
the previous version, VAD V2 exhibited steady laminar Couette flow in the thin 
blood gap between the rotor body and the pump housing. In VAD V3, small 
toroidal vortices known as Taylor vortices appear to form at all rotational speeds 
and flow rates (Figure 5-10). These vortices form between two concentric 
cylinders, where the inner cylinder is rotating at a constant speed, typically when 
the cylinders are long and the gap between them is narrow [104], as is the case 
of VAD V3. At a critical rotational speed, the centrifugal forces of the inner 
cylinder exceed the viscous forces of the fluid and the pressure gradient across 
the cylinder gap, causing the vortices to form. These vortices are still in the 
laminar regime, considered a type of super-laminar flow, but can transition to 
completely turbulent vortex flows at high rotational speeds [105]. These vortices 
may have a negative impact on the design of the VAD V3. The vortices increase 
the flow or residence time of fluid around the rotor body creating a longer path 
through the secondary flow, i.e. the time for the fluid particles to travel around the 
rotor body and back through the center opening will be prolonged compared to 
the speed traveling through a steady laminar Couette flow [106]. This in turn 
increases the amount of time blood is exposed to the pump surfaces and 
potential exposure to higher shear stresses. Further, the vortices can cause 
areas of increased shear stress and increase the torque of the rotor body [107]. 
Further work will need to be completed to mitigate or control the formation of 
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these vortices, potentially through changing the surface profile of the rotor body 
or lower pump housing [108]. Appendix E, Figure E-3 details how the vortices 
form around the rotor body during the transient CFD simulation from 0.010 to 
0.50 seconds of flow time. 
 
Figure 5-10. Velocity plots of the impeller/rotor surface and surrounding flow in a 
cut plot planar to the pump inlet center opening with black iso-flow 
lines displayed to show detail of Taylor vortices formation at various 




5.3.5 Shear Stress and Residence Time 
Figure 5-11 shows shear rate distributions at a planar cut plot through the 
center of the pump inlet. Most of the fluid domain is subjected to low shear rates 
(less than 10,000 s-1) with areas of higher rates at the impeller/rotor and pump 
housing surfaces. The largest concentrations of higher shear rates appear on the 
surfaces of the rotor body and lower pump housing at the thin blood gap area. 
The formation of Taylor vortices in the rotor body/lower pump housing blood gap 
create concentrated areas of higher shear rates (Figure 5-11). Other 
concentration areas for higher shear rates include the pump volute surfaces, 
impeller surfaces, and at the top of the pump housing, which may be attributed to 
the tertiary flow path in this area caused by the impeller shroud. For all cases, 
shear rates at the pump surface increase with increased rotational speed and 
flow rate. Additional shear rate plots are shown in Figure 5-12. 








































































































































































































































































































































Figure 5-13 shows wall shear stress distribution plots of the impeller/rotor 
and pump housing surfaces. Concentrations of high shear stress are seen at the 
impeller blade extension tips and around the rotor body and pump housing in the 
blood gap region. Even at lowest operating point, 3000 RPM at 0.50 L/min, there 
are small areas in these regions that exceed the critical value of 150 Pa for 
hemolysis. At the highest operating point, 5000 RPM at 3.50 L/min, shear 
stresses in these areas increase significantly with select spots exceeding 450 Pa. 
The maximum shear stresses generated at the impeller/rotor surface and the 
pump housing surface were 752 Pa and 759 Pa, respectively, at 5000 RPM at 
3.50 L/min and 176 mmHg. A similar computational study of the HeartWare 
HVAD and Thoratec HeartMate II generated maximum wall shear stresses of 
2198 Pa and 2018 Pa, respectively, at 5.00 L/min and 70 mmHg [102]. Although 
these values are from a higher flow rate, this comparison is encouraging. In 
addition, the maximum shear stress generated in the flow domain for the HVAD 
was 3440 Pa and 1559 Pa for the HeartMate compared to 1777 Pa for the 
















































































































Histograms of the volumetric shear stress distribution and the residence 
time shear stress distribution are shown in Figure 5-14. For all rotational speeds 
and flow rates, the majority of pump fluid volume (more than 50%) is in the shear 
stress range of 0 – 10 Pa. As the rotational speed and flow rate increases, the 
volumetric distribution of the histograms shift slightly to the right, indicating that 
more flow is exposed to higher shear stresses at these elevated conditions. 79% 
 
Figure 5-14. Histograms of the volumetric distribution of shear stress (Left) and 
the residence time distribution of shear stress (Right) of the 
Inspired Pediatric VAD V3 at rotational speeds of 3000, 4000, and 
5000 RPM and flow rates of 0.50, 2.00, and 3.50 L/min. 
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of the volume is in the range of 0 – 10 Pa for 3000 RPM at 0.50 L/min compared 
to 65% for 5000 RPM at 3.50 L/min. At the higher end of shear stresses, < 1% of 
the volume is in the 150 – 1000 Pa range for 3000 RPM at 0.50 L/min compared 
to 2.3% for 5000 RPM at 3.50 L/min. Still, even at 3.50 L/min (the target design 
point for the Pediatric VAD), 94% of the volume in the flow domain is exposed to 
shear stresses at or below 100Pa. The highest residence times within the VAD 
occur at the lowest flow rate, 0.50 L/min, and the overall summation of residence 
times greatly decreases as the flow rate is increased. As with the volumetric 
distribution, the majority of residence time for all rotational speeds and flow rates 
resides at or below 100 Pa. 
Figure 5-15 shows histograms of volume and residence shear stress 
distribution considering the critical thresholds of 9, 50, and 150 Pa. The highest 
operating point of 5000 RPM at 3.50 L/min has the highest volume percentage 
for each threshold, with approximately 2.3% (3.4 mL) above the threshold for 
hemolysis (150 Pa). This compares to 0.20% (0.025 mL) for the HVAD and 
0.40% (0.031 mL) for the HeartMate II [101], [102]. In another similar 
computational study, Fraser et al. found that the Thoratec CentriMag and 
UltraMag pumps, centrifugal pumps similar to the Inspired Pediatric VAD V3, 
both had minimal volume (<0.5%) above the 150 Pa threshold, at a flow rate of 3 
L/min [68]. Summed mesh cell residence times above the critical 150 Pa 
threshold are low, with all rotational speeds and flow rates below 6 seconds, 
which is encouraging. Average mesh cell residence times are low (< 7.00E-04 




Figure 5-15. Histograms of the volumetric distribution of shear stress (Top) and 
the residence time distribution of shear stress (Bottom) of the 
Inspired Pediatric VAD V3 at critical thresholds of 9 Pa (vWF 




stress range of 0 – 9 Pa. These residence time values compare favorably with 
the CentriMag and UltraMag for all shear stress thresholds [68]. A plot of average 
cell residence times is shown in Appendix E, Figure E-4. 
 In blood pumps, areas of flow stagnation or recirculation, especially at the 
pump surfaces, can become prone to thrombus formation and platelet 
aggregation [109], [110] and surface areas with shear rates below 250 s-1 have 
been shown to have clot formation [111]. Figure 9 shows iso-surface plots 
detailing areas within the fluid volume where shear rates are below 250 s-1, 100 
s-1, and flow velocities are below 0.20 m/s. A velocity threshold of 0.20 m/s was 
chosen to visually display areas where flow stagnation and recirculation may 
occur. For all rotational speeds and flow rates, there are low velocity regions in 
the pump inlet and pump outlet mainly towards the boundary layer of the fully 
developed flow, with areas diminishing as the flow rate is increased. At flow rates 
of 0.50 and 1.0 L/min, small amounts of low velocity may be seen in the center of 
the impeller eye. Appendix E, Figures E-5 and E-6 show directional velocity 
vectors in the pump outlet region. Some areas of flow recirculation and flow 
retrograde do exist at lower flow rates 0.50 and 1.0 L/min but these areas 
disappear at 2.0 L/min or greater. There are significant areas that experience 
shear rates less than 250 s-1 in the pump inlet, outlet, in the center opening of the 
rotor body, and in the center of the impeller blade channels. Areas of low shear 
within the pump inlet, outlet, and impeller blade channels diminish as flow rate is 
increased, with the area within the rotor body center opening remaining. Although 
significant areas are present, especially at 3000 RPM and 0.50 L/min, the 
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majority of volume is in the center of the flow channels for each of these regions 
and are not in contact with any pump surfaces. Only surface areas experiencing 
low shear rates should be concerning for clot formation. Blood at shear rates 
 
Figure 5-16. Summary of iso-surface plots detailing areas within the fluid volume 
where shear rates are below 250 s-1 (possible clot formation at 
pumping surfaces), 100 s-1 (areas where blood behaves as a non-
Newtonian fluid), and flow velocities are below 0.20 m/s (areas of 
possible flow stagnation and recirculation), for various rotational 
speeds and flow rates. 
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above 100 s-1 behaves as an incompressible Newtonian fluid, so areas below this 
threshold are of interest from a fluid modeling perspective.  
 
5.3.6 Study Limitations 
The Inspired Pediatric VAD V3 is the next iteration of a novel device that 
has been developed based on an evolution of a variety of different prototype 
versions; however, the simulations and numerical predictions presented in this 
study have not yet been validated empirically with a VAD V3 prototype. The 
MagLev motor system and controller have been fully evaluated, with next steps 
involving evaluation of these components coupled with the VAD V3 pump design. 
Full bench testing in a mock circulatory loop and acute animal implantation are 
planned for the next development phase of this project. 
Although SolidWorks Flow Simulation is a powerful CFD tool with many 
unique facets, it does not provide the implementation of user defined variables 
and/or scalars in the solver portion of the software. Due to these limitations, a full 
picture of the VAD V3’s hemocompatibility could not be completed in this study. 
Although shear stress, shear rate, and residence time distributions are useful 
indicators for blood damage, estimations of the distribution of plasma-free 
hemoglobin using a Eulerian transport equation and hemolysis index (HI) using a 
power-law model have been employed by others in different software packages 
[68], [101], [112], [113]. A full characterization of these variables in the Inspired 
Pediatric VAD V3 may be useful in comparison to other published blood pump 




In this study, CFD simulations were used to characterize the novel 
Inspired Pediatric VAD V3. Numerically predicted hemodynamic performance 
and volumetric shear stress and fluid residence times were presented as well as 
an evaluation of the wall shear stress distributions across the impeller/rotor and 
pump housing surfaces. The phenomena of Taylor vortices were observed due to 
the new elongated design of the rotor body around its perimeter for all rotational 
speeds and flow rates. Areas of low shear rates and low flow velocities were 
observed in the pump outflow channel which will require further investigation as it 
pertains to potential clot formation. 
Future development efforts include full characterization of performance 
and safety of the Inspired Pediatric VAD V3, in vitro testing in static and dynamic 
mock circulatory loop models and in vivo testing in acute and chronic large 
animal studies. Our ultimate goal is to translate this new device into clinical 
practice, which may greatly benefit pediatric HF patients who remain in dire need 














Through the research and development efforts described in this 
dissertation, the aim for this project was achieved as evidenced by completion of 
the design, development, and evaluation of the impeller and pump housing 
components of the Inspired Pediatric VAD through three progressive iterations 
(VAD V1, V2 and V3). The last design V3 integrated the MagLev motor system, 
achieved desired pump operational parameters (flows of 0.5 – 3.5 L/min at 
pressures of 40 – 150 mmHg), and exhibited promising hemocompatibility 
predictions. 
 
6.1.1 Impeller and Pump Design 
Established turbomachinery calculation and dimensional analysis 
techniques were leveraged to formulate the impeller and pump housing designs 
of the Inspired Pediatric VAD. These traditional approaches, which are intended 
for much larger industrial pump applications, were combined with data and 




Since VADs are a new and evolving technology, established design theory 
is not readily available. Using a combination of traditional calculations and VAD 
specific elements, a hybrid design approach was developed and tailored 
specifically for the Inspired System. This approach was used to establish the 
basic design of the Inspired Pediatric VAD and will be used in future 
development efforts to design additional single-use pumps (neonate, adult, 
pulmonary support). This design approach was integrated into a spreadsheet to 
accelerate the process and to facilitate the development of future impeller design 
iterations (Figures 6-1, 6-2). 
 
 
Figure 6-1. Example of dimensionless constants calculations in the Inspired 






6.1.2 CFD Simulation 
Computational fluid dynamics (CFD) models were constructed for each 
Inspired Pediatric VAD design iteration. Simulations were conducted for each 
design, resulting in hydrodynamic, hemodynamic, and torque/force data that 
informed iterative design decisions. Additionally, data from these simulations 
were used in the design of the MagLev motor for the Inspired Universal MagLev 
system. Key engineering design requirements of the Inspired Pediatric VAD were 
identified through CFD simulations including: the need for a center opening 
through the rotor body to counter-act axial lift forces generated by the impeller; 
the need for impeller blade extensions to induce uniform flow in the entire pump 
 




volute; the possible need for a center post to promote uniform return flow through 
the rotor body center opening; and the formation of Taylor vortices along the 
radial blood gap. Additionally, areas of high and low shear as well as low flow 
velocity were identified for future design improvement. 
 
6.1.3 Prototype Testing 
A shaft driven Inspired Pediatric VAD V2 was constructed and 
successfully tested in a static flow loop model. Important hydrodynamic and 
impeller hydraulic torque data were generated from this study. These data were 
utilized in the design of the MagLev motor system. Additionally, the processes 
and protocols developed during this study will be used in future VAD prototype 
bench testing efforts. 
 
6.1.4 Final Design 
A final Inspired Pediatric VAD geometry, VAD V3, was created, integrating 
the novel MagLev motor into the design, and was evaluated through CFD 
simulations and hemodynamic analysis. The geometry of the VAD V3 design is 
unique, with an elongated rotor body and relatively small impeller diameter. The 
design was predicted to achieve the desired flow and pressure requirements. 
Hemodynamically, the design compares closely with current clinically available 
devices, with most of the flow volume below the critical shear stress threshold of 
150 Pa, although further analysis is required. Prototype VAD V3 devices are 
currently being fabricated (Figure 6-3), using a mixture of injection-molded and 
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additive manufacturing components for precise production of the parts with the 
optimal geometry, and will be tested in the next phase of this project. 
 
6.2 Future Work 
Although a large development effort has been completed in the Inspired 
Pediatric VAD project, there are additional outstanding engineering challenges to 
be addressed as the pump design progresses towards the final clinical-grade 




Figure 6-3. Injection molded and additive manufacturing components of the 
Inspired Pediatric VAD V3 prototype currently under development. 
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6.2.1 In Vitro Mock Circulatory Loop Testing 
To complete the first phase of the Inspired Pediatric VAD project, in vitro 
bench testing and in vivo acute large animal experiments are planned to evaluate 
the VAD V3 design. Bench testing will be performed in a pediatric dynamic mock 
flow loop model simulating a 20-kg, three-year-old pediatric patient. The pediatric 
mock flow loop model consists of a pneumatically driven silicone ventricle, 
venous return reservoir, and systemic vasculature components. The loop will be 
used to characterize the hemodynamic performance of VAD V3. The mock flow 
loop model has a proximal resistance (afterload), an elevated storage element 
(preload), compliance element, and a distal resistance, which can be tuned to 
simulate pediatric pressures and flows for normal, heart failure, hypertension, 
hypotension, hypovolemia, and hypervolemia test conditions. The hemodynamic 
performance will be characterized over the entire operational range and 
compared for each baseline test condition. VAD V3 will be tested in both a static 
loop condition, for H-Q curve data generation, and a dynamic loop condition 
(beating ventricle). Mock loop testing results will be compared to previously 
completed CFD simulations. This empirical data will be valuable in improving the 
CFD modeling and the Pediatric VAD design. 
 
6.2.2 Large Animal Model Studies 
Following the successful completion of the mock loop study, VAD V3 will 
be tested in two acute large ovine animal studies (~20kg). The animals will be 
cannulated to allow connection of the VAD prototype and the device will be 
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evaluated to confirm stable hemodynamic support for up to 4 hours. The Inspired 
VAD will be evaluated for ease of use of the driver, pump insertion, degree of 
blood trauma (hemolysis levels must be <10 mg/dl), and evidence of thrombus at 
necropsy.  
 
6.2.3 Design Improvements 
The impeller and pump housing designs of the Inspired Pediatric VAD 
may benefit from several improvements based on lessons learned during the 
research described in this dissertation: A few key potential improvements 
include: 
 
- Slow velocity areas were identified at the pump outlet at lower flows 
(below 1.00 L/min) (Figures E-5, E-6). Curving the outlet to be more of 
a radial discharge design, where the cutwater and outlet follow the 
curvature of the volute before gradually turning perpendicularly 
outward may help alleviate some of the low flow velocity areas. 
 
- Currently the pump outflow is attached to the lower pump housing and 
the pump inflow is attached to the upper housing. Additionally, these 
ports are perpendicular to each other, meaning cannula tubing exits 
the pump in two different orientations. For ease of pump assembly and 
to improve pump ergonomics and usability, the pump ports could be 
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molded into the upper pump housing and exit the pump parallel to 
each other. 
 
- A shroud was added to the top of the impeller blades to improve 
impeller efficiency and reduce flow recirculation between blades. A 
negative to this feature was excess reverse flow leakage above the 
shroud that entered into the pump inflow stream and caused a large 
amount of flow pre-rotation at lower flow rates (Figure E-9). A possible 
improvement may be to remove a portion of the shroud at the entrance 
of the pump blades, creating a “partially open” impeller design. This 
change may result in improved flow dynamics at the impeller eye and 
would still provide a shroud as flow progresses through the blade 
passages, mitigating any recirculation between blades. 
 
- An improvement that may increase impeller efficiency is to add small 
diffuser blades in the middle of the impeller blade passages. These 
diffusers should be about half the length of the impeller blades, follow 
the same arc length as the blades, and thinner. A previous study 
explored the use of these secondary diffuser blades in the design of a 
centrifugal blood pump and found they had a positive effect on 




- The formation of Taylor vortices in the radial blood gap surrounding the 
pump rotor body was an unexpected outcome in the analysis of VAD 
V3. These vortices appear to increase flow time around the impeller 
and create concentrated areas of higher shear. Several improvements 
may be implemented to help reduce the formation of the vortices. As 
described in previous studies, the addition of steps or corrugations on 
the rotor body surface may help reduce, or at least, control the 
formation of vortices. This improvement may also help to reduce the 
number of vortices that are formed and control the locations in which 
they do form. Another solution may be the addition of a secondary 
impeller at the base of the rotor body. This impeller may help to 
increase flow around the rotor body, drawing fluid from the pump 
volute down along the sides and back up through the center opening. It 
may also help to distribute the pressure more evenly between the 
pump volute and rotor body center opening. This design improvement 
is likely to cause a large change to the overall fluid dynamics within the 
pump, but may be investigated with future simulations. 
 
6.2.4 Parametric Analysis 
With the required geometry defined for VAD V3 (with the integration of the 
MagLev motor), optimization of several components of the design may now be 
performed. Utilizing a series of CFD simulations, parametric analysis looking at 
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how overall pump efficiency is affected by design elements, such as blade 
discharge angle, blade thickness, radial and axial gaps may be performed. 
 
6.2.5 Additional Pump Designs 
Although the development of the Inspired Pediatric VAD is not completed 
(we have not achieved a design freeze), lessons learned from this dissertation 
research may be applied to the design and development of future single-use 
pumps to be used with the Inspired Universal MagLev System. Development of a 
pediatric pump/oxygenator hybrid for cardiopulmonary support is planned, with 
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: ADDITIONAL DESIGN EQUATIONS 
 
Equations A.1 – A.6. Solving for the Euler Velocity Triangle at the impeller 
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𝐶2! = 𝐾2!/2𝑔𝐻 = 0.1385	2 × 9.81𝑚 𝑠𝑒𝑐!8 × 1.93	𝑚𝑒𝑡𝑒𝑟	ℎ𝑒𝑎𝑑 = 0.850	
𝑚 𝑠𝑒𝑐⁄   (A.2) 
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! + 4.05	𝑚 𝑠𝑒𝑐⁄






















Equations A.7 – A.12. Solving for the Euler Velocity Triangle at the impeller 
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Equations A.13 – A.16. Solving for the Euler Velocity Triangle at the impeller 
blade discharge while accounting for flow slip. 
 
𝐶3!E = 𝑢!(𝑆 − 𝜙 tan𝛽!) = 6.10	𝑚 𝑠𝑒𝑐⁄ (0.563 − .115 tan 22.50°) = 3.14𝑚 𝑠𝑒𝑐⁄    (A.13) 
 
𝐶!E = 5𝐶2!! + 𝐶3!E
! =	5	0.850	𝑚 𝑠𝑒𝑐⁄
! + 3.14	𝑚 𝑠𝑒𝑐⁄
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Equations A.17 – A.20. Solving for the Euler Velocity Triangle at the impeller 
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: CHAPTER 3 SUPPLEMENT 
 
Table B-1. Summary of Reynolds number calculations for pump inlet and 
impellers for Pumps V1 and V2 at Q = 3.5 L/min and various 
rotational speeds (n).  
 
 Pump Inlet - Flow through a Circular Pipe 
















 Impeller - Flow across a Rotating Disk 
 Rotational Speed, 
n (RPM) 
Impeller 













6000 67590       
 Rotational Speed, 
n (RPM) 
Impeller 
































Table B-2. Four meshing schemes with increasing mesh refinement compared 
to respective number of mesh cells and converged values for ΔP and 
Torque for both Pump V1 and Pump V2 at Q = 3.5 L/min and n = 
4255 RPM. 
 
 Mesh Scheme Number of Cells ΔP (mmHg) Torque (N-mm) 
Pump V1 
1 84,102 98.08 5.49 
2 188,412 97.20 5.62 
3 484,712 90.80 5.79 
4 1,143,915 89.70 6.10      
Pump V2 
1 41,593 132.30 6.88 
2 123,504 123.40 7.19 
3 317,965 119.99 7.38 
4 690,285 119.50 7.40 
 
 
B.1 CFD Simulation Time Step 
SolidWorks Technical Reference [62], [114] recommends setting a 
calculation time step of less than 1/50 of the revolution period for transient (time 
dependent) simulations with rotating regions (Δta). When dealing specifically with 
impellers, it recommends taking into account the absolute time required for one 
blade to move from its position to the position of the neighboring blade (our 
impeller has six blades) (Δtb). Taking these recommendations into consideration, 
















		= 		0.01	𝑠𝑒𝑐𝑜𝑛𝑑𝑠	           (B.3) 
 
 156 
Time steps based on both of these methods were calculated for various 
impeller rotational speeds and are shown in Table B-3. 
 
Table B-3. Calculated simulation time steps based on two recommended 
methods for various impeller rotational speeds. 
Calculated Simulation Time Steps 
Speed (RPM) Δta   (sec) Δtb   (sec) 
1000 0.00120 0.0100 
2000 0.00060 0.0050 
3000 0.00040 0.0033 
4000 0.00030 0.0025 
5000 0.00024 0.0020 
6000 0.00020 0.0017 
 
 In these CFD simulations, the automatic time step tool was used in 
SolidWorks with a threshold set at the finest calculated time step from Table B-3, 
0.0002 seconds. On average, the automatic time steps in SolidWorks were much 






Table B-4. Mean wall shear stress (WSS) values for all surfaces on the pump 
impeller and pump housing for both versions Pump V1 and V2 at 
rotational speeds 4255 to 6000 RPM. 
 
Impeller Surface Mean WSS (Pa) 
Speed (RPM) Pump V1 Pump V2 
4255 73.56 67.32 
4500 78.50 71.55 
5000 88.86 81.00 
5500 98.91 91.93 
6000 110.51 101.84 
   
Pump Housing Surface Mean WSS (Pa) 
Speed (RPM) Pump V1 Pump V2 
4255 54.43 70.83 
4500 55.78 80.30 
5000 65.61 88.65 
5500 74.70 103.68 
6000 84.49 115.30 
 
 
Figure B-1. Plotted converged ΔP values versus number of mesh cells for four 
meshing schemes for both Pump V1 and V2 at Q = 3.5 L/min and n 








































































































































































































































































































































































































































































































































































































































: CHAPTER 4 SUPPLEMENT 
 
Table C-1. DC motor back electromotive force (EMF) at corresponding rotational 
speeds, generated voltage, calculated back EMF constant, Ke, and 






Back EMF, Ke 
(V/rpm) 
400 1.34 0.00335 
800 2.68 0.00335 
1000 3.31 0.00331 
1500 4.92 0.00328 

















Table C-2. DC motor voltage (V) and current (A) at multiple rotational speeds 
against no load. Motor power (W) was calculated from measured 
voltage, current. Motor torque (𝛕DC) was calculated from measured 
current and the derived motor torque constant, Kt.  
Speed (RPM) Voltage (V) Current (A) Power (W) 𝛕DC Kt*I (N*mm) 
500 2.291 0.222 0.51 7.009 
1000 3.902 0.235 0.92 7.419 
1500 5.525 0.250 1.38 7.892 
2000 7.162 0.272 1.95 8.587 
2500 8.770 0.288 2.53 9.092 
3000 10.323 0.299 3.09 9.439 
3500 11.942 0.308 3.68 9.724 
4000 13.442 0.321 4.31 10.134 
4500 15.040 0.331 4.98 10.450 
5000 16.566 0.342 5.67 10.797 
5500 18.215 0.350 6.38 11.049 
6000 19.754 0.360 7.11 11.365 
 
Table C-3. DC motor voltage (V) and current (A) at multiple rotational speeds 
while driving the Pediatric VAD impeller without fluid. The total torque 
of the VAD without fluid (𝛕Total, Dry) was calculated from measured 
current and Kt. The torque due to friction (𝛕Friction) of the shaft and 
seal was determined as the difference between the total torque of the 
dry system (𝛕Total, Dry) and the total torque of the DC motor (𝛕DC). 
Speed 






1000 4.301 0.505 2.17 15.94 8.32 
2000 7.545 0.545 4.11 17.21 8.79 
3000 10.629 0.582 6.19 18.37 9.16 
4000 13.787 0.565 7.79 17.84 7.83 
5000 16.811 0.601 10.10 18.97 8.17 




Figure C-1. Plot of calculated DC motor torque against no load versus rotational 
speed. The linear line of best fit and subsequent linear equation 
were used to determine the motor damping coefficient (Bm) and the 
kinetic friction of the motor (Tfm) and to calculate DC motor torque 




Table C-4. Collected parameters of the Inspired Pediatric VAD in the Static Flow 
Loop (SFL) at 500 RPM. Total torque of the VAD in the SFL (𝛕Total) 
was calculated from measured current and Kt. The hydraulic torque 
(𝛕Hydro) of the impeller was the resulting net torque between the 
calculated total torque (𝛕Total) of the fluid filled system, the total base 
torque of the DC motor (𝛕DC), and the torque due to friction of the 



























500 0.12 0.01 0.00 0.01 2.784 0.492 1.37 15.53 8.52 7.23 -0.21 
500 0.00 2.00 0.50 1.50 2.778 0.508 1.41 16.04 8.52 7.23 0.29 
 
 
Table C-5. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop 


























1000 0.35 1.30 -0.92 2.22 4.483 0.506 2.27 15.97 8.52 7.62 -0.17 
1000 0.15 7.63 0.37 7.26 4.484 0.501 2.25 15.82 8.52 7.62 -0.33 
1000 0.00 10.30 0.85 9.45 4.485 0.499 2.24 15.75 8.52 7.62 -0.39 
 
 
Table C-6. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop 


























1500 0.67 2.44 -3.51 5.95 6.186 0.526 3.25 16.61 8.52 8.02 0.06 
1500 0.40 12.82 -1.03 13.85 6.188 0.520 3.22 16.42 8.52 8.02 -0.13 
1500 0.20 19.89 0.39 19.50 6.192 0.513 3.18 16.20 8.52 8.02 -0.35 




Table C-7. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop 


























2000 0.99 3.87 -7.65 11.52 7.843 0.550 4.31 17.36 8.52 8.42 0.42 
2000 0.80 14.89 -4.84 19.73 7.846 0.544 4.27 17.17 8.52 8.42 0.23 
2000 0.60 24.41 -2.60 27.01 7.847 0.539 4.23 17.02 8.52 8.42 0.08 
2000 0.40 32.79 -0.62 33.41 7.849 0.535 4.20 16.89 8.52 8.42 -0.05 
2000 0.20 39.01 0.62 38.39 7.850 0.532 4.18 16.80 8.52 8.42 -0.14 
2000 0.00 45.23 1.32 43.91 7.852 0.526 4.13 16.61 8.52 8.42 -0.33 
 
 
Table C-8. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop 


























2500 1.33 3.87 -13.55 17.42 9.499 0.598 5.68 18.88 8.52 8.82 1.54 
2500 1.00 27.27 -7.50 34.77 9.502 0.593 5.63 18.72 8.52 8.82 1.38 
2500 0.75 40.32 -4.03 44.35 9.505 0.588 5.59 18.56 8.52 8.82 1.23 
2500 0.50 52.30 -1.23 53.53 9.507 0.580 5.51 18.31 8.52 8.82 0.97 
2500 0.25 60.60 0.68 59.92 9.509 0.576 5.48 18.18 8.52 8.82 0.85 











Table C-9. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop 


























3000 1.70 5.41 -21.94 27.35 11.131 0.661 7.36 20.87 8.52 9.21 3.13 
3000 1.50 21.22 -17.44 38.66 11.132 0.655 7.29 20.68 8.52 9.21 2.94 
3000 1.25 41.75 -11.78 53.53 11.135 0.650 7.24 20.52 8.52 9.21 2.79 
3000 1.00 58.73 -7.65 66.38 11.137 0.643 7.16 20.30 8.52 9.21 2.56 
3000 0.75 72.27 -3.93 76.20 11.142 0.634 7.06 20.02 8.52 9.21 2.28 
3000 0.50 85.44 -0.90 86.34 11.139 0.633 7.05 19.98 8.52 9.21 2.25 
3000 0.25 93.33 0.73 92.60 11.143 0.630 7.02 19.89 8.52 9.21 2.15 
3000 0.00 100.33 1.80 98.53 11.145 0.627 6.99 19.79 8.52 9.21 2.06 
 
 
Table C-10. Collected parameters of the Inspired Pediatric VAD in the Static Flow 


























3500 2.10 5.67 -32.99 38.66 12.768 0.723 9.23 22.83 8.52 9.61 4.69 
3500 2.00 13.70 -30.99 44.69 12.770 0.717 9.16 22.64 8.52 9.61 4.50 
3500 1.75 37.20 -23.43 60.63 12.773 0.714 9.12 22.54 8.52 9.61 4.41 
3500 1.50 58.71 -17.19 75.90 12.776 0.706 9.02 22.29 8.52 9.61 4.16 
3500 1.25 77.48 -11.90 89.38 12.780 0.698 8.92 22.04 8.52 9.61 3.90 
3500 1.00 93.35 -7.32 100.67 12.776 0.705 9.01 22.26 8.52 9.61 4.12 
3500 0.75 107.25 -3.78 111.03 12.800 0.720 9.22 22.73 8.52 9.61 4.60 
3500 0.50 119.94 -1.09 121.03 12.805 0.721 9.23 22.76 8.52 9.61 4.63 
3500 0.25 130.07 1.00 129.07 12.806 0.715 9.16 22.57 8.52 9.61 4.44 






Table C-11. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop 


























4000 2.48 6.70 -46.91 53.61 14.491 0.854 12.38 26.96 8.52 10.01 8.43 
4000 2.25 32.66 -38.20 70.86 14.480 0.868 12.57 27.40 8.52 10.01 8.87 
4000 2.00 55.86 -31.23 87.09 14.488 0.861 12.47 27.18 8.52 10.01 8.65 
4000 1.75 82.31 -23.24 105.55 14.494 0.841 12.19 26.55 8.52 10.01 8.02 
4000 1.50 103.47 -16.86 120.33 14.496 0.839 12.16 26.49 8.52 10.01 7.96 
4000 1.25 121.38 -11.64 133.02 14.499 0.833 12.08 26.30 8.52 10.01 7.77 
4000 1.00 138.64 -7.23 145.87 14.500 0.828 12.01 26.14 8.52 10.01 7.61 
4000 0.75 154.45 -3.40 157.85 14.502 0.826 11.98 26.08 8.52 10.01 7.55 
4000 0.50 165.10 -0.64 165.74 14.504 0.822 11.92 25.95 8.52 10.01 7.42 
4000 0.25 174.40 1.30 173.10 14.504 0.821 11.91 25.92 8.52 10.01 7.39 






Table C-12. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop 


























4500 2.91 4.57 -63.52 68.09 16.063 0.941 15.12 29.71 8.52 10.41 10.78 
4500 2.75 24.49 -56.84 81.33 16.071 0.935 15.03 29.52 8.52 10.41 10.59 
4500 2.50 53.71 -47.99 101.70 16.073 0.934 15.01 29.49 8.52 10.41 10.56 
4500 2.25 81.12 -38.70 119.82 16.079 0.918 14.76 28.98 8.52 10.41 10.05 
4500 2.00 110.86 -29.57 140.43 16.082 0.911 14.65 28.76 8.52 10.41 9.83 
4500 1.75 132.06 -23.01 155.07 16.087 0.900 14.48 28.41 8.52 10.41 9.49 
4500 1.50 155.45 -16.09 171.54 16.090 0.891 14.34 28.13 8.52 10.41 9.20 
4500 1.25 171.55 -11.14 182.69 16.093 0.888 14.29 28.03 8.52 10.41 9.11 
4500 1.00 186.33 -6.91 193.24 16.098 0.875 14.09 27.62 8.52 10.41 8.70 
4500 0.75 202.93 -2.82 205.75 16.101 0.870 14.01 27.47 8.52 10.41 8.54 
4500 0.50 215.46 -0.38 215.84 16.104 0.865 13.93 27.31 8.52 10.41 8.38 
4500 0.25 223.70 1.49 222.21 16.106 0.860 13.85 27.15 8.52 10.41 8.22 






Table C-13. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop 


























5000 3.39 4.57 -82.18 86.75 17.663 1.002 17.70 31.63 8.52 10.80 12.31 
5000 3.25 25.63 -75.62 101.25 17.667 0.998 17.63 31.51 8.52 10.80 12.18 
5000 3.00 57.67 -65.33 123.00 17.668 0.991 17.51 31.29 8.52 10.80 11.96 
5000 2.75 85.84 -55.68 141.52 17.675 0.980 17.32 30.94 8.52 10.80 11.61 
5000 2.50 119.47 -44.85 164.32 17.677 0.974 17.22 30.75 8.52 10.80 11.42 
5000 2.25 144.61 -36.50 181.11 17.684 0.961 16.99 30.34 8.52 10.80 11.01 
5000 2.00 168.92 -29.36 198.28 17.685 0.958 16.94 30.24 8.52 10.80 10.92 
5000 1.75 190.31 -22.13 212.44 17.689 0.946 16.73 29.87 8.52 10.80 10.54 
5000 1.50 214.02 -16.42 230.44 17.686 0.957 16.93 30.21 8.52 10.80 10.89 
5000 1.25 231.02 -10.61 241.63 17.689 0.949 16.79 29.96 8.52 10.80 10.64 
5000 1.00 244.80 -6.91 251.71 17.691 0.941 16.65 29.71 8.52 10.80 10.38 
5000 0.75 260.31 -2.89 263.20 17.698 0.928 16.42 29.30 8.52 10.80 9.97 
5000 0.50 273.43 -0.20 273.63 17.700 0.922 16.32 29.11 8.52 10.80 9.78 
5000 0.25 284.98 1.68 283.30 17.704 0.908 16.08 28.67 8.52 10.80 9.34 






Table C-14. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop 


























5500 3.88 -0.88 -103.21 102.33 19.063 1.072 20.44 33.84 8.52 11.20 14.12 
5500 3.75 13.44 -97.87 111.31 19.033 1.066 20.29 33.65 8.52 11.20 13.93 
5500 3.50 48.42 -86.29 134.71 19.073 1.063 20.27 33.56 8.52 11.20 13.84 
5500 3.25 83.78 -73.58 157.36 19.040 1.060 20.18 33.46 8.52 11.20 13.74 
5500 3.00 115.27 -63.36 178.63 19.060 1.051 20.03 33.18 8.52 11.20 13.46 
5500 2.75 148.17 -53.52 201.69 19.051 1.045 19.91 32.99 8.52 11.20 13.27 
5500 2.50 178.38 -44.18 222.56 19.031 1.039 19.77 32.80 8.52 11.20 13.08 
5500 2.25 205.89 -35.63 241.52 19.063 1.025 19.54 32.36 8.52 11.20 12.64 
5500 2.00 228.62 -28.66 257.28 19.073 1.018 19.42 32.14 8.52 11.20 12.42 
5500 1.75 253.44 -21.91 275.35 19.081 1.011 19.29 31.92 8.52 11.20 12.20 
5500 1.50 273.20 -15.24 288.44 19.083 1.006 19.20 31.76 8.52 11.20 12.04 
5500 1.25 290.32 -10.29 300.61 19.095 0.994 18.98 31.38 8.52 11.20 11.66 
5500 1.00 310.60 -5.98 316.58 19.100 0.985 18.81 31.10 8.52 11.20 11.37 
5500 0.75 319.54 -2.54 322.08 19.106 0.972 18.57 30.69 8.52 11.20 10.96 
5500 0.50 335.32 0.27 335.05 19.111 0.956 18.27 30.18 8.52 11.20 10.46 
5500 0.25 345.77 2.00 343.77 19.118 0.954 18.24 30.12 8.52 11.20 10.40 





Table C-15. Collected parameters of the Inspired Pediatric VAD in the Static Flow Loop 


























6000 4.27 0.64 -125.91 126.55 20.574 1.171 24.09 36.97 8.52 11.60 16.85 
6000 4.00 46.05 -111.75 157.80 20.588 1.151 23.70 36.34 8.52 11.60 16.22 
6000 3.75 85.74 -98.87 184.61 20.593 1.143 23.54 36.08 8.52 11.60 15.97 
6000 3.50 123.43 -87.34 210.77 20.598 1.130 23.28 35.67 8.52 11.60 15.56 
6000 3.25 160.23 -73.63 233.86 20.602 1.118 23.03 35.30 8.52 11.60 15.18 
6000 3.00 191.58 -63.77 255.35 20.606 1.104 22.75 34.85 8.52 11.60 14.73 
6000 2.75 225.04 -53.04 278.08 20.610 1.098 22.63 34.66 8.52 11.60 14.54 
6000 2.50 252.29 -43.69 295.98 20.616 1.080 22.27 34.10 8.52 11.60 13.98 
6000 2.25 278.03 -35.56 313.59 20.620 1.074 22.15 33.91 8.52 11.60 13.79 
6000 2.00 300.32 -28.48 328.80 20.623 1.063 21.92 33.56 8.52 11.60 13.44 
6000 1.75 321.99 -21.34 343.33 20.624 1.055 21.76 33.31 8.52 11.60 13.19 
6000 1.50 338.96 -15.51 354.47 20.623 1.065 21.96 33.62 8.52 11.60 13.50 
6000 1.25 356.79 -10.27 367.06 20.625 1.055 21.76 33.31 8.52 11.60 13.19 
6000 1.00 372.32 -6.07 378.39 20.630 1.046 21.58 33.02 8.52 11.60 12.90 
6000 0.75 388.75 -2.65 391.40 20.635 1.033 21.32 32.61 8.52 11.60 12.49 
6000 0.50 402.07 0.24 401.83 20.638 1.019 21.03 32.17 8.52 11.60 12.05 
6000 0.25 412.88 2.04 410.84 20.645 0.996 20.56 31.44 8.52 11.60 11.32 











Figure C-2. Calibrated Cannon-Fenske style viscometer submerged in a 37° C 
water bath to measure the viscosity of the blood analogue solution. 
sample 
 
Figure C-3. (Left) Laser-based tachometer to measure impeller rotational speed, 




Figure C-4. Various images of static flow loop (SFL) construction with a view 
(Bottom Right) of the variable DC power supply, multimeters, and 






















: VAD V2 ADDITIONAL SIMULATIONS 
 
D.1 Additional VAD V2 CFD Simulations 
Additional CFD simulations than those found in Chapter 4 were conducted 
for VAD V2, comparing results to hydrodynamic performance and hydraulic 
torque values found empirically using the SFL model data. Six operational points 
(test conditions) of the pump were selected for rotational speeds of 1000, 2000, 
3000, 4000, 5000, and 6000 RPM at corresponding flow rates of 0.15, 0.60, 1.00, 
2.00, 2.50, and 3.50 L/min, respectively (Table D-1). Each of these test 
conditions were used to construct the computational fluid dynamics (CFD) model 
and perform simulations for further evaluation in SolidWorks Flow Simulation 
(SolidWorks 2019, Dassault Systèmes, Waltham, MA). The fluid properties of the 
previous analysis were adjusted to match the measured density and viscosity of 
the blood-analogue solution used in the SFL model. These simulations were 
conducted at each test condition to produce pump pressure (ΔP), impeller 
torque, and impeller forces (X, Y, Z vectors) for each rotational speed and flow 
rate. In addition to the original Pediatric VAD geometry (CFD1), an additional 
geometry (CFD2) without the center opening through the rotor body was created 
(Figure D-1) to mimic the geometry of the empirical prototype (EXP1). This 
geometry was also simulated under all test conditions to compare the torques 
and forces of the impeller to those of the empirical prototype and the original 
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Pediatric VAD geometry. An overview of SFL and CFD model experiments are 
presented in Figure D-2. 
 
Figure D-1. Cut-views detailing the original, Inspired Pediatric VAD V2 geometry 
with rotor body center opening and lower pump housing center post 
used for CFD1 and of the modified VAD2 geometry without center 
opening used for CFD2 to mimic the geometry of the Inspired 
Pediatric VAD V2 shaft driven prototype (EXP1). 
Figure D-2. A flow chart detailing the SFL (using the empirical pump prototype, 
EXP1) and CFD (using the pump geometries CFD1 and CFD2) 
experiments, the tested pump conditions (rotational speed or flow 
rate and rotational speed) for each experiment, and the collected 
variables for each experiment (pump pressure, flow rate, impeller 
torque and impeller x, y, and z forces). 
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D.2 Empirical vs. CFD Results 
Results for the empirical cases (1000, 2000, 3000, 4000, 5000, and 6000 
RPM and 0.15, 0.60, 1.00, 2.00, 2.50, and 3.50 L/min) and CFD simulation 
results for pump geometries CFD1 and CFD2 are presented in Table D-1. CFD 1 
and CFD2 simulation results were similar for all cases with less than a 2% 
EXP1 - Empirical Prototype in Static Flow Loop 
     Hydraulic  










(mmHg) (mNm) X Y Z 
1000 0.15 7.63 0.37 7.26 -0.33 - - - 
2000 0.60 24.41 -2.60 27.01 0.08 - - - 
3000 1.00 58.73 -7.65 66.38 2.57 - - - 
4000 2.00 55.86 -31.23 87.09 8.65 - - - 
5000 2.50 119.47 -44.85 164.32 11.43 - - - 
6000 3.50 123.43 -87.34 210.77 15.56 - - - 
         
CFD1 – Inspired VAD V2 
     Hydraulic  










(mmHg) (mNm) X Y Z 
1000 0.15 7.63 -0.46 8.09 0.59 0.01 0.00 0.02 
2000 0.60 24.41 -8.11 32.52 1.99 0.06 0.01 0.05 
3000 1.00 58.73 -15.59 74.32 3.89 0.21 -0.02 0.16 
4000 2.00 55.86 -75.02 130.88 6.72 -0.34 0.71 0.23 
5000 2.50 119.47 -90.60 210.07 9.82 0.48 0.40 0.65 
6000 3.50 123.43 -181.04 304.47 13.85 0.46 0.30 1.46 
         
CFD2 – Inspired VAD V2 without Center Opening 
     Hydraulic  










(mmHg) (mNm) X Y Z 
1000 0.15 7.63 -0.43 8.06 0.59 0.01 0.00 0.15 
2000 0.60 24.41 -7.62 32.03 1.95 0.07 0.01 0.68 
3000 1.00 58.73 -15.72 74.45 3.78 0.15 0.04 1.49 
4000 2.00 55.86 -76.08 131.94 6.52 0.29 0.11 2.71 
5000 2.50 119.47 -91.65 211.12 9.45 0.40 0.16 4.12 
6000 3.50 123.43 -180.70 304.13 13.46 0.54 0.26 5.96 
         
Table D-1. Empirical results for the Inspired Pediatric VAD prototype in the SFL 
(EXP1) compared to CFD results for the two different impeller/rotor 
geometries (CFD1 and CFD2) including generated pressure head 
(ΔP) and impeller/rotor hydraulic torque (𝛕Hydro).
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difference for all generated ΔP values and less than a 4% difference for all 
generated 𝛕Hydro values. CFD simulations produced varied results compared to 
the empirical prototype (EXP1) for both compared values (Figures D-3 and D-4). 
CFD results for 𝛕Hydro were higher at lower rotational speeds than EXP1 with a 
difference of 155% for the 1000 RPM case. Conversely, CFD generated ΔP 
values showed less difference at lower rotational speeds (1000 to 3000 RPM, 
10% to 17% difference in ΔP) with the difference in ΔP value increasing as 
rotational speed increased (up to a 33% difference).  
 
 
Figure D-3. Pressure vs. flow rate values for the Inspired Pediatric VAD V2 prototype 
compared with CFD simulation results CFD1 and CFD 2 for rotational 





Figure D-4. Hydraulic torque values for the Inspired Pediatric VAD V2 prototype 
compared with CFD simulation results CFD1 and CFD 2 for rotational 











D.3 Axial Impeller Force 
Tangential and radial forces (X and Y vectors) were relatively small (0.5 N 
or less) for CFD1 and CFD2 for all rotational speeds. The axial force (Z vector) in 
the positive direction increased with raising the rotational speed, likely due to the 
lift force created by the impeller rotation, for CFD1 and CFD2. CFD2 (solid 
impeller/rotor) generated much higher axial forces (5.96 N at 6000 RPM) than 
CFD1 (impeller/rotor with center opening) (1.46 N at 6000 RPM) likely due to the 
additional secondary flow path around the impeller/rotor added as a design 
feature to help negate generated lift forces, as illustrated in Figure D-5. These 
results confirmed the previous decision to include the center opening in the rotor 
design.  
 
Figure D-5. Impeller/rotor force in the axial (Z-axis) direction relative to rotational 







: CHAPTER 5 SUPPLEMENT 
 
Table E-1. Summary of Reynolds number calculations for Inspired Pediatric 
VAD V3 pump inlet and impeller for flow rates (Q) 0.50 – 4.00 L/min 
and rotational speeds (n) 3000, 4000, and 5000 RPM.  
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4000 65767  
5000 82209  
      
VAD Inlet - Flow through a Circular Pipe 













1.00 0.53466 1028 
2.00 1.0693 2056 
2.50 1.3367 2571 
3.50 1.8713 3599 



















































































Figure E-2. Generated pressure (ΔP) and torque values for meshing schemes 1 
– 4 at 3000 RPM and 1.00 L/min. Meshing Scheme 3 showed less 
than a 0.50% difference in converged ΔP value and less than a 1% 
difference in converged torque value compared to the finest 




Table E-2. Summary of computational fluid dynamics (CFD) predictions of head 
pressure, impeller hydraulic torque, and impeller translational forces 
for Inspired Pediatric VAD V2 at rotational speeds 3000, 4000, and 
5000 RPM and various flow rates. 















X Y Z 
3000 2.50 100.00 41.38 58.62 4.43 0.10 0.24 0.62 
3000 1.50 100.00 32.27 67.73 4.03 0.07 0.22 0.28 
3000 1.00 100.00 28.90 71.10 3.67 0.11 0.11 0.12 
3000 0.50 100.00 27.48 72.52 3.46 0.07 0.02 0.01 
         















X Y Z 
4000 3.00 100.00 -16.28 116.28 7.02 0.18 0.39 0.96 
4000 2.00 100.00 -26.30 126.30 6.36 0.19 0.24 0.53 
4000 1.00 100.00 -31.10 131.10 5.95 0.08 0.16 0.27 
4000 0.50 100.00 -40.77 140.77 5.63 0.02 0.11 0.07 
         















X Y Z 
5000 4.00 100.00 -80.90 180.90 10.52 0.36 0.50 1.61 
5000 3.00 100.00 -99.17 199.17 9.82 -0.70 0.63 1.22 
5000 2.00 100.00 -102.91 202.91 8.96 0.15 0.13 0.46 
5000 1.00 100.00 -117.80 217.80 7.96 0.16 0.11 0.30 









Table E-3. Summary of computational fluid dynamics (CFD) predictions of head 
pressure, impeller hydraulic torque, and impeller translational forces 
for Inspired Pediatric VAD V3 at rotational speeds 3000, 4000, and 
5000 RPM and various flow rates. 
 
Table E-4. Summary of data for additional CFD simulation cases for Inspired 
Pediatric VAD V3 at rotational speeds 1000, 2000, and 6000 RPM. 















X Y Z 
1000 0.15 -0.11 7.63 7.74 1.20 0.01 0.03 -0.09 
2000 0.60 -8.44 24.41 32.85 4.35 0.00 0.04 -0.08 
6000 3.50 -171.66 123.43 295.09 25.85 0.11 1.14 2.15 
 















X Y Z 
3000 2.50 140.62 200.00 59.38 9.37 0.12 0.41 0.83 
3000 1.00 -14.71 58.73 73.44 8.56 0.01 0.20 0.13 
3000 0.50 125.50 200.00 74.50 8.39 0.07 0.20 -0.02 
         















X Y Z 
4000 3.00 85.31 200.00 114.69 14.35 0.14 0.73 1.30 
4000 2.00 -68.97 55.86 124.83 13.69 0.11 0.60 0.45 
4000 1.00 67.57 200.00 132.43 13.10 0.10 0.40 0.35 
         















X Y Z 
5000 4.00 21.06 200.00 178.94 20.36 178.94 21.06 200.00 
5000 3.50 13.47 200.00 186.53 19.89 186.53 13.47 200.00 
5000 2.50 -80.81 119.47 200.28 19.62 200.28 -80.81 119.47 






































































































































Figure E-4. Average mesh cell residence times at critical shear stress thresholds 
of 9 Pa (vWF damage), 50 Pa (platelet activation), and 150 Pa 







Figure E-5.  Velocity flow field vectors at the Inspired Pediatric VAD V3 pump 
outlet. At low flows of 1.00 L/min or lower, select areas of flow 





Figure E-6.  Velocity flow field vectors at the Inspired Pediatric VAD V3 pump 
outlet. At higher flows above 1.00 L/min, all flow vectors travel 
toward the pump outlet eliminating stagnation and recirculation 






Figure E-7.  Velocity flow field vectors inside the Inspired Pediatric VAD V3 





Figure E-8.  Velocity flow field vectors inside the Inspired Pediatric VAD V3 




Figure E-9.  Velocity flow field vectors at the Inspired Pediatric VAD V3 inlet at 







: VAD V3 ADDITIONAL SIMULATIONS 
 
F.1 V3 Computational Fluid Dynamics (CFD) Simulation - Newtonian Fluid 
For comparative purposes, additional CFD simulations of the Inspired 
Pediatric VAD V3 were conducted assuming laminar flow and blood as a 
Newtonian fluid with a density of 𝜌 = 1060 kg/m3 at 37° C and a viscosity of μ = 
0.0035 Pa-s, for all flow cases at 5000 RPM. Previous CFD analysis of the VAD 
V2 were performed assuming blood as a Newtonian fluid because, although 
blood is considered a non-Newtonian fluid, it is shear thinning, and at the high 
shear rates (>100 s-1) typically found in rotary blood pumps, it behaves as an 
incompressible Newtonian fluid [64]. This assumption has been used in many 
previous related CFD studies [65]–[67].  
 
F.2 V3 Computational Fluid Dynamics (CFD) Simulation - Turbulent Flow 
Since a portion of the flow within the VAD was predicted to be in the 
laminar-to-turbulent transition range for some cases, additional simulations were 
performed using a turbulent flow model. SolidWorks Flow Simulation uses a 
version of the k-ε turbulence model to solve the Reynolds Averaged Navier-




Comparison of generated head pressure and hydraulic torque values at 5000 
RPM for laminar Newtonian and non-Newtonian solvers and turbulent flow 
modeling are shown in Figure F-1 and Table F-1. 
 
Table F-1. Computationally predicted hydrodynamic values at 5000 RPM for 
CFD simulation cases: laminar flow, non-Newtonian fluid; laminar 
flow, Newtonian fluid; turbulent flow, Newtonian fluid.  















X Y Z 
5000 1.00 -10.82 200.00 210.82 18.07 -0.07 0.43 0.46 
5000 2.50 -80.81 119.47 200.28 19.62 0.00 0.73 1.13 
5000 3.50 13.47 200.00 186.53 19.89 0.41 1.10 1.85 
5000 4.00 21.06 200.00 178.94 20.36 0.27 1.17 2.22 
         















X Y Z 
5000 1.00 -7.22 200.00 207.22 13.08 -0.02 0.41 1.74 
5000 2.50 2.20 200.00 197.80 14.55 -0.03 0.74 2.04 
5000 3.50 13.59 200.00 186.41 15.27 0.13 1.25 2.63 
5000 4.00 20.37 200.00 179.63 15.50 0.10 1.36 3.04 
         















X Y Z 
5000 1.00 -31.21 200.00 231.21 11.52 -0.21 0.28 0.33 
5000 2.50 -22.00 200.00 222.00 13.03 0.57 0.88 1.12 
5000 3.50 -4.55 200.00 204.55 13.92 0.14 1.34 1.46 







Figure F-1.  A) Computationally predicted characteristic pressure-flow curves (H-
Q) and, B) computationally predicted impeller/rotor hydraulic torque 
values at 5000 RPM for CFD simulation cases: laminar flow, non-
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ACTIVE FUNDED GRANTS  
R43HL152894-01 (PI MAST: Tompkins, co-PI UofL: Koenig, Slaughter)  
8/21/2020 – 9/20/2021 $278,487  
NIH SBIR phase I Grant (MAST, Louisville KY)  
Development of a partial occlusion device to aid coring and anastomosis of the 
aorta 
The major goal of this project is to demonstrate feasibility of a partial occlusion 
device (CardiAction) to facilitate minimally invasive surgery for implant of 
mechanical circulatory support (MCS) devices. 
Role: Principle Investigator (40% effort) 
 
R43HL142385-01 (PI MAST: Tompkins, co-PI UofL: Koenig, Slaughter)  
9/24/2018 – 8/30/2021 $303,817  
NIH SBIR phase I Grant (MAST, Louisville KY)  
Development of a sutureless LVAD outflow graft anastomotic quick-connect 
system 
The major goal of this project is to demonstrate feasibility of a sutureless graft to 
aorta anastomotic device (Uniti Connect) to facilitate minimally invasive 
implantation of mechanical circulatory support (MCS) devices. 
Role: Principle Investigator (40% effort) 
 
R43HL144214-01 (PI IT: Dasse, co-PI UofL: Koenig, Slaughter)  
7/1/2018 – 6/30/2021 $415,921  
NIH SBIR phase I Grant (Inspired Therapeutics, Merritt Island FL)  
Development of a universal maglev driver for five pediatric cardiac and 
respiratory applications  
The major goal of this project is to demonstrate feasibility of pediatric Universal 
MagLev system designed to provide up to 30-days of mechanical circulatory 
support (MCS) as left ventricular assist device (LVAD). 
Role: Doctoral Student, Tompkins – (10% effort) 
 
R43HL142337-01 (PI CH: Jimenez, co-PI UofL: Koenig, Slaughter)  
9/24/2018 – 8/30/2021 $311,131  
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NIH SBIR phase I Grant (Cor Habere, Louisville KY)  
Left Atrial Appendage (LAA) closure device for stroke prevention in patients with 
AFIB 
The major goal of this project is to complete pre-clinical development of a left 
atrial appendage (LAA) closure device (StrokeShield) designed to prevent 
strokes in patients with atrial fibrillation (AFIB). 
Role: CH Engineer, Tompkins (10% effort) 
 
COMPLETED GRANTS 
R44HL123120-01 (PI: Spence)  
05/01/2014 – 04/30/2015 $320,765  
NIH SBIR Phase I & II Fast Track (SCR Inc., Louisville KY)  
Development of SVAD System for HF Therapy  
The objective of this proposal was to complete the engineering development and 
pre-clinical testing of the SVAD system (SCR, Louisville KY & Heartware Inc., 
Framingham MA) to provide partial cardiac assist in patients with less advanced 
stage heart failure (HF). 
Role: Co-Investigator, Tompkins 
 
KSTC-184-512-13-153 (PI: Spence)  
01/01/2013 – 12/31/2015   
Kentucky Science and Technology Corporation (KSTC) Grant (SCR Inc., 
Louisville KY)  
Counterpulsation device with integrated ECG sensing  
The major goal of this proposal was to complete development of the Symphony 
system (Abiomed, Danvers MA) by integrating a subcutaneous lead system for 
ECG detection, signal conditioning, and control. 
Role: Co-Investigator, Tompkins 
 
2R43HL102981-02A (PI: Spence)  
04/01/2012 – 03/31/2014 $1,616,503  
NIH SBIR Phase II grant (SCR Inc., Louisville KY)  
Subcutaneous ECG Sensing  
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The major goal of this project was to complete development of novel 
subcutaneous ECG leads integrated with the Symphony device (Abiomed, 
Danvers MA) and portable driver.  
Role: SCR Engineer, Tompkins 
 
2R44HL088760-02 (PI: Spence)  
05/15/2009 – 04/12/2012 $1,580,486  
NIH SBIR Phase II Grant (SCR Inc., Louisville KY)  
Portable pneumatic driver for counterpulsation therapy 
The major goals of this project were to (1) complete engineering development, 
(2) demonstrate reliability and hemocompatibility, and (3) demonstrate safety and 
biocompatibility of a portable pneumatic driver for a novel counterpulsation 
device (CPD) to treat early stage heart failure. 
Role: SCR Engineer, Tompkins 
 
2R44HL083586-02A1 (PI: Spence)  
08/01/2008 –07/31/2011 $1,440,170  
NIH SBIR Phase II Grant (SCR Inc., Louisville KY)  
Development of a Counterpulsation Therapy Device 
The major goals of this project were to (1) complete engineering development 
and surgical procedures, (2) demonstrate reliability and hemocompatibility, and 
(3) demonstrate safety and biocompatibility of a novel counterpulsation device 
(CPD) to treat early stage heart failure.  
Role: SCR Engineer, Tompkins 
 
R43HL102981 (PI: Spence)  
03/01/2010 –02/28/2011 $244,850  
NIH SBIR Phase I Grant (SCR Inc., Louisville KY)  
Subcutaneous ECG Sensing 
The major goal of this project was to demonstrate feasibility of a novel 
subcutaneous ECG to be integrated with the Symphony device and portable 
driver. 
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